<SEC-DOCUMENT>0001575872-23-000571.txt : 20230418
<SEC-HEADER>0001575872-23-000571.hdr.sgml : 20230418
<ACCEPTANCE-DATETIME>20230417173445
ACCESSION NUMBER:		0001575872-23-000571
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20230417
FILED AS OF DATE:		20230418
DATE AS OF CHANGE:		20230417

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VCI Global Ltd
		CENTRAL INDEX KEY:			0001930510
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-FACILITIES SUPPORT MANAGEMENT SERVICES [8744]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			N8
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41678
		FILM NUMBER:		23824932

	BUSINESS ADDRESS:	
		STREET 1:		B03-C-8 MENARA 3A, KL ECO CITY, NO. 3
		STREET 2:		JALAN BANGSAR
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			59200
		BUSINESS PHONE:		603 2201 5249

	MAIL ADDRESS:	
		STREET 1:		B03-C-8 MENARA 3A, KL ECO CITY, NO. 3
		STREET 2:		JALAN BANGSAR
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			59200
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>cm299_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; width: 100%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
6-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT
OF FOREIGN PRIVATE ISSUER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO RULE 13a-16 OR 15d-16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDER
THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the month of April 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commission
File Number: 001-41678</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VCI
Global Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Translation
of registrant&rsquo;s name into English)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B03-C-8
Menara 3A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KL
Eco City, No. 3 Jalan Bangsar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>59200
Kuala Lumpur</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
20-F&nbsp;&#9746; Form 40-F&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes&nbsp;&#9744;
No&nbsp;&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
&ldquo;Yes&rdquo; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; width: 100%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2023, VCI Global Limited, a British Virgin Islands business company (the &ldquo;Company&rdquo;), entered into an underwriting
agreement (the &ldquo;Underwriting Agreement&rdquo;) with Boustead Securities, LLC, as representative (the &ldquo;Representative&rdquo;)
of the underwriters named therein (the &ldquo;Underwriters&rdquo;), pursuant to which the Company agreed to sell to the Underwriters
in a firm commitment initial public offering (the &ldquo;Offering&rdquo;) of an aggregate of 1,280,000 of the Company&rsquo;s ordinary
shares, no par value per share (the &ldquo;Ordinary Shares&rdquo;), at a public offering price of $4.00 per share. The Company has also
granted the Underwriters a 45-day option to purchase up to additional 192,000 Ordinary Shares to cover over-allotments, if any. The Ordinary
Shares were offered by the Company pursuant to a registration statement on&nbsp;Form F-1, as amended&nbsp;(File No. 333-268109), originally
filed with the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on November 1, 2022, which was declared effective
by the SEC on March 30, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriting Agreement contains customary representations and warranties that the parties thereto made to, and solely for the benefit
of, the other party in the context of all of the terms and conditions of that Underwriting Agreement and in the context of the specific
relationship between the parties. The provisions of the Underwriting Agreement and schedules and exhibits thereto, including the representations
and warranties contained therein respectively, are not for the benefit of any party other than the parties to such documents and agreements
and are not intended as documents for investors and the public to obtain factual information about the current state of affairs of the
parties to those documents and agreements. Rather, investors and the public should look to other disclosures contained in the Company&rsquo;s
filings with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 17, 2023, the Company closed the Offering. The total net proceeds to the Company from the Offering, after deducting discounts,
expenses allowance and expenses, were approximately $4,535,650. A final prospectus relating to this Offering was filed with the Commission
on April 14, 2023. The Ordinary Shares were previously approved for listing on The Nasdaq Capital Market and commenced trading under
the ticker symbol &ldquo;VCIG&rdquo; on April 13, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
closing, the Company issued to the Underwriters warrants to purchase an aggregate of up to 89,600 Ordinary Shares at per share price
of $4.00, expiring April 13, 2028.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s officers and directors, all existing stockholders who held Ordinary Shares prior to the initial public offering have
agreed, subject to certain exceptions, not to offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise
dispose of any Ordinary Shares or other securities convertible into or exercisable or exchangeable for Ordinary Shares for a period from
6 to 12 months without the prior written consent of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summary of the terms of the Underwriting Agreement and Underwriter&rsquo;s Warrant is subject to, and qualified in its entirety
by reference to, copies of the Underwriting Agreement, and Underwriter&rsquo;s Warrant that are filed as Exhibit 1.1, and 4.1 to this Report
on Form 6-K and are incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2023, the Company issued three press releases furnished herewith as Exhibit 99.1, 99.2, and 99.3 announcing the pricing and
trading of the Offering and closing its first day of trading on The Nasdaq Capital Market. On April 17, 2023, the Company issued a press
release furnished herein as Exhibit 99.4, announcing the closing of the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under
the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #FEFEFE">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VCI
    Global Limited</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #FEFEFE">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FEFEFE">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 17, 2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Victor Hoo</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FEFEFE">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Victor
    Hoo</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FEFEFE">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
INDEX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FEFEFE">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.65in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.15in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="cm299_ex1-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">1.1</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="cm299_ex1-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Underwriting
    Agreement dated April 13, 2023, by and between the Company and the Representative</FONT></A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="cm299_ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">4.1</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="cm299_ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form
    of Representative&rsquo;s Warrants</FONT></A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="cm299_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">99.1</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="cm299_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Press
    Release on Pricing of the Company&rsquo;s Initial Public Offering</FONT></A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="cm299_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">99.2</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="cm299_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Press
    Release on Trading of the Company&rsquo;s Initial Public Offering</FONT></A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="cm299_ex99-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">99.3</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="cm299_ex99-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Press
    Release on Closing Its First Day of Trading of the Company&rsquo;s Initial Public Offering</FONT></A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><A HREF="cm299_ex99-4.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><A HREF="cm299_ex99-4.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
    Release on Closing of the Company&rsquo;s Initial Public Offering</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>cm299_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VCI GLOBAL LMITED </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>UNDERWRITING
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">April 13, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boustead Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6 Venture, Suite 395</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Irvine, CA 92618</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Keith Moore, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Daniel J. McClory, Managing Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This underwriting agreement
(this &ldquo;<B>Agreement</B>&rdquo;) constitutes the agreement between <B>VCI Global Limited</B>, a company incorporated in the British
Virgin Islands (the &ldquo;<B>Company</B>&rdquo;), on the one hand, and&nbsp;<B>Boustead Securities, LLC</B>&nbsp;(the &ldquo;<B>Representative</B>&rdquo;),
for itself as underwriter and as representative of the several underwriters listed on <B><U>Schedule I</U></B> hereto (the &ldquo;<B>Underwriters</B>&rdquo;),
on the other hand, pursuant to which the Underwriters shall serve as the underwriters for the Company in connection with the proposed
offering (the &ldquo;<B>Offering</B>&rdquo;) by the Company of its Offered Securities (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company proposes, subject
to the terms and conditions stated herein, to issue and sell to the Underwriters an aggregate of 1,280,000 authorized but unissued ordinary
shares (the &ldquo;<B>Firm Shares</B>&rdquo;), without par value, of the Company (such shares generally, the &ldquo;<B>Ordinary Shares</B>&rdquo;),
and to grant the Representative the option to purchase an aggregate of up to 192,000 additional Ordinary Shares (the &ldquo;<B>Option
Shares</B>&rdquo;) as may be necessary to cover over-allotments made in connection with the Offering. The Firm Shares and Option Shares
are collectively referred to as the &ldquo;<B>Offered Securities</B>.&rdquo; The Offered Securities and the Representative&rsquo;s Warrant
(as defined below) and the Warrant Shares (as defined below) are collectively referred to herein as the &ldquo;<B>Securities</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby confirms
its agreement with the Representative as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Section 1. Fees and Expenses; Survival and Other
Activities</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Underwriting
Discount; Representative&rsquo;s Warrants; Expenses</U>.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Underwriting
Discount</U>. The Underwriters shall be entitled to receive an underwriting discount equal to seven percent (7%) of the gross proceeds
from the sale of the Offered Securities on a Closing Date, as defined in Section 3(c) herein, which will be paid to and allocated by the
Representative among the Underwriters or selling syndicate and soliciting dealers.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Accountable
Expense Allowance</U>. The Underwriters shall be entitled to receive a non-accountable expense allowance equal to one percent (1%) of
the gross proceeds from the sale of the Offered Securities on a Closing Date, which will be paid to and allocated by the Representative
among the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representative&rsquo;s
Warrants</U>. The Company hereby agrees to issue to the Representative (and/or its permitted designees) on a Closing Date, a warrant or
warrants, as applicable (in the form attached as <B><U>Exhibit A</U></B> hereto, the &ldquo;<B>Representative&rsquo;s Warrant</B>&rdquo;)
to purchase the number of Ordinary Shares equal to seven percent (7%) of the number of Firm shares and Option Shares, if any, issued in
the Offering (&ldquo;<B>Warrant Shares</B>&rdquo;).</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">The Representative&rsquo;s
Warrants will be exercisable for a term of five (5) years from the effective date (the &ldquo;<B>Effective Date</B>&rdquo;) of the Registration
Statement (as defined below) at an initial exercise price equal to the price per share paid by investors in the Offering. The Representative&rsquo;s
Warrants shall include a &ldquo;cashless&rdquo; exercise feature, and shall contain provisions for registration rights for the Representative&rsquo;s
Warrants and the underlying Ordinary Shares, as set forth in the Representative&rsquo;s Warrants. The Representative understands and agrees
that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representative&rsquo;s Warrants and the Warrant
Shares during the one hundred eighty (180) days after the Effective Date and by its acceptance thereof shall agree that it will not sell,
transfer, assign, pledge or hypothecate the Representative&rsquo;s Warrants, or any portion thereof, or be the subject of any hedging,
short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period
of one hundred eighty (180) days following the Effective Date to anyone other than the circumstances listed under FINRA Rule 5110(e)(2).
Delivery of the Representative&rsquo;s Warrants shall be made on a Closing Date and shall be issued in the name or names and in such authorized
denominations as the Representative may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>.
Whether or not the transactions contemplated by this Agreement and the Registration Statement are consummated or this Agreement is terminated,
the Company hereby agrees to pay all costs and expenses incident to the Offering, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
expenses in connection with the preparation, printing, formatting for EDGAR and filing of the Registration Statement, and any and all
amendments and supplements thereto and the mailing and delivering of copies thereof to the Underwriters and dealers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
fees and expenses in connection with filings with FINRA&rsquo;s Public Offering System;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
fees, disbursements and expenses of the Company&rsquo;s counsel and accountants in connection with the registration of the Offered Securities
under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;) and the Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
reasonable expenses in connection with the qualifications of the Offered Securities for offering and sale under state or blue sky laws,
when applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
fees and expenses in connection with listing the Offered Securities on the Nasdaq Stock Market (&ldquo;<B>Nasdaq</B>&rdquo;), including
DTC eligibility;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">F.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
reasonable travel expenses of the Company&rsquo;s officers, directors and employees and any other expense of the Company incurred in connection
with attending or hosting meetings with prospective purchasers of the Offered Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">G.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
stock transfer taxes incurred in connection with this Agreement or the Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">H.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
cost and charges of any transfer agent or registrar for the Offered Securities; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">I.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Underwriters&rsquo;
accountable out-of-pocket expenses in the aggregate amount of $208,000, including Underwriters&rsquo; counsel&rsquo;s fees of up to $100,000
($25,000 of which have been advanced by the Company to the Underwriter). In addition, the Company has advanced to the Underwriter approximately
$ for other expenses related to the Offering. Any such advances shall be applied against the aggregate out-of-pocket accountable expense
allowance, which is capped at $208,000, and any unused portion of the advances will be returned to the Company to the extent not actually
incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that this Agreement
is terminated pursuant to Section 9 hereof, or subsequent to a Material Adverse Effect (as defined in Section 2(g)), the Company will
pay all documented out-of-pocket and unreimbursed expenses of the Underwriters (including fees and disbursements of Underwriters&rsquo;
counsel) incurred in connection herewith which shall be limited to expenses which are actually incurred as allowed under FINRA Rule 5110
and in any event, the aggregate amount of such expenses to be paid or reimbursed by the Company directly or indirectly to or on behalf
of the Underwriters shall not exceed $208,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival
and Other Activities</U>. Notwithstanding anything to the contrary contained herein, the Company&rsquo;s obligation to pay fees actually
earned and payable and to reimburse expenses actually incurred and reimbursable pursuant to Section 1 hereof and which are permitted to
be reimbursed under FINRA Rule 5110(g)(5)(A), will survive any expiration or termination of this Agreement. Nothing in this Agreement
shall be construed to limit the ability of the Underwriters or their Affiliates to pursue, investigate, analyze, invest in, or engage
in investment banking, financial advisory or any other business relationship with Persons (as defined below) other than the Company. As
used herein (i) &ldquo;<B>Persons</B>&rdquo; means an individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any
kind and (ii) &ldquo;<B>Affiliate</B>&rdquo; means any Person that, directly or indirectly through one or more intermediaries, controls
or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>Section 2. Representations,
Warranties and Covenants of the Company</B>. The Company hereby represents, warrants and covenants to the Underwriters, as of the date
hereof, and as of the Closing Date, except as set out in the Registration Statement as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Securities
Law Filings</U>. The Company has filed with the Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) a registration
statement on Form F-1 (Registration File No.: 333-268109) under the Securities Act and the rules and regulations of the Commission (the
&ldquo;<B>Rules and Regulations</B>&rdquo;) promulgated thereunder and under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange
Act</B>&rdquo;). At the time of the Effective Date, the Registration Statement and amendments met the requirements of Form F-1 under the
Securities Act. The Company will file with the Commission pursuant to Rules 430A and 424(b) under the Securities Act, a final prospectus
included in such registration statement relating to the Offering and the underwriting thereof and has advised the Representative of all
further information (financial and other) with respect to the Company required to be set forth therein. Such registration statement, including
the exhibits thereto, as amended at the date of this Agreement, is hereinafter called the &ldquo;<B>Registration Statement</B>&rdquo;;
such prospectus in the form in which it appears in the Registration Statement as amended at the date of this Agreement is hereinafter
called the &ldquo;<B>Prospectus</B>.&rdquo; If the Company has filed or files an abbreviated registration statement pursuant to Rule 462(b)
under the Securities Act (the &ldquo;<B>Rule 462 Registration Statement</B>&rdquo;), then any reference herein to the term Registration
Statement shall include such Rule 462 Registration Statement. Any preliminary prospectus included in the Registration Statement or filed
with the Commission under the Securities Act is hereinafter called a &ldquo;<B>Preliminary Prospectus</B>.&rdquo; All references in this
Agreement to financial statements and schedules and other information that is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo;
&ldquo;referenced,&rdquo; &ldquo;set forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, any Preliminary Prospectus or
the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules
and other information that is or is deemed to be incorporated by reference in the Registration Statement, any Preliminary Prospectus or
the Prospectus, as the case may be. The Registration Statement has been declared effective on the date hereof. The Company shall, prior
to the Closing Date, file with the Commission a Form 8-A providing for the registration under the Exchange Act of the Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Assurances</U>.
The Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules as required
by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, at
all other subsequent times until the Closing Date, complied in all material respects with the Securities Act and the applicable Rules
and Regulations and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading (<I>provided,&nbsp;however</I>, that the preceding representations and warranties contained
in this sentence shall not apply to any statements or omissions made in reliance upon and in conformity with information furnished in
writing to the Company by the Representative expressly for use therein, which information shall consist solely of (i) the names of the
Underwriters appearing in the Prospectus, (ii) the statement regarding delivery of the Ordinary Shares set forth on the cover page of
the Prospectus, (iii) the securities dealer discount referred to in the second paragraph of the section of the Prospectus captioned &ldquo;Underwriting&rdquo;,
(iv) the information set forth in the fourth paragraph of the section of the Prospectus captioned &ldquo;Underwriting&rdquo; and (v) the
table showing the number of securities to be purchased by each Underwriter (the &ldquo;<B>Underwriter Information</B>&rdquo;). Each Preliminary
Prospectus, as of its date, complies in all material respects with the Securities Act and the applicable Rules and Regulations. The Prospectus,
as of its date, complies in all material respects with the Securities Act and the applicable Rules and Regulations. As of its date, each
Preliminary Prospectus and the Prospectus did not and will not contain as of the date thereof any untrue statement of a material fact
or omit to state a s fact necessary in order to make the statements therein, in light of the circumstances under which they were made,
not misleading (<I>provided,&nbsp;however</I>, that the preceding representations and warranties contained in this sentence shall not
apply to any Underwriter Information). All post-effective amendments to the Registration Statement reflecting facts or events arising
after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein have
been so filed with the Commission. There are no documents required to be filed with the Commission in connection with the transaction
contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite
time period. The Company is eligible to use &ldquo;free writing prospectuses&rdquo; in connection with the Offering pursuant to Rules
164 and 433 under the Securities Act. Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the
Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable
Rules and Regulations. Each such free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under
the Securities Act or that was prepared by or on behalf of or used by the Company complies or will comply in all material respects with
the requirements of the Securities Act and the applicable Rules and Regulations. The Company has not and will not, without the prior consent
of the Representative, prepare, use or refer to, any free writing prospectus. Each such free writing prospectus shall be deemed to be
included as part of the Registration Statement for purposes of this Agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Offering
Materials</U>. The Company has delivered, or will as promptly as practicable deliver, to the Underwriters complete conformed copies of
the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof, and conformed copies
of the Registration Statement (without exhibits), any Preliminary Prospectus, any free writing prospectus and the Prospectus, as amended
or supplemented, in such quantities and at such places as the Underwriters reasonably request. Neither the Company nor any of its directors
and officers has distributed and none of them will distribute, prior to the Closing Date, any offering material in connection with the
offering and sale of the Offered Securities other than the Prospectus, the Registration Statement, and any free writing prospectus authorized
in advance by the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company (the &ldquo;<B>Subsidiaries</B>&rdquo;) are described in the Registration Statement
to the extent required by the Rules and Regulations. The Company owns, directly or indirectly, all of its capital stock or other equity
interests of each Subsidiary free and clear of any liens, charges, security interests, encumbrances, rights of first refusal, preemptive
rights or other restrictions (collectively, &ldquo;<B>Liens</B>&rdquo;) except as disclosed in the Registration Statement or the Prospectus,
and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable
and free of preemptive or similar rights to subscribe for or purchase securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing (where applicable) under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation or material default of any of the provisions of its respective certificate or articles of incorporation, bylaws
or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in
good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of this Agreement,
the Representative&rsquo;s Warrant or any other agreement or instrument entered into between the Company and the Underwriters (&ldquo;<B>Transaction
Documents</B>&rdquo;), (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial
or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability
to perform in any material respect on a timely basis its obligations under this Agreement or the Offering (any of (i), (ii) or (iii),
a &ldquo;<B>Material Adverse Effect</B>&rdquo;) and to the knowledge of the Company, no action, claim, suit, investigation or proceeding
(including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened
(&ldquo;<B>Proceeding</B>&rdquo;) has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and the Offering and otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of this Agreement by the Company and each of the other Transaction Documents and the consummation
by it of the transactions contemplated hereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Company&rsquo;s Board of Directors (the &ldquo;<B>Board of Directors</B>&rdquo;) or the Company&rsquo;s
shareholders in connection therewith other than in connection with the Required Approvals (as defined below). This Agreement and each
other Transaction Document to which it is a party has been duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms,
except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws
of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions
may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement, the other Transaction Documents to which it is
a party and the transactions contemplated hereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s
or any Subsidiary&rsquo;s memorandum and articles of association, certificate or articles of incorporation, bylaws or other organizational
or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become
a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to
others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement,
credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company
or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject
to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or
other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state
securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the
case of each of clauses (ii) and (iii), such conflict, default or violation could not reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of this Agreement, the other Transaction Documents to which it is a party
and the transactions contemplated hereby where the failure to obtain any such consent, waiver, authorization or order of, give any notice
to, or make any filing or registration would not, singularly or in the aggregate, have or reasonably be expected to result in a Material
Adverse Effect, other than: (i) the filing with the Commission of the final Prospectus as required by Rule 424 under the Securities Act,
(ii) application to the Nasdaq for the listing of the Offered Securities for trading thereon in the time and manner required thereby and
(iii) such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<B>Required Approvals</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
of the Securities</U>. The Offered Securities are duly authorized and, when issued and paid for in accordance with this Agreement, the
other Transaction Documents to which it is a party, and the terms of the Offering as described in the Prospectus, will be duly and validly
issued, fully paid and non-assessable, and free and clear of all Liens. The Representative&rsquo;s Warrant has been duly authorized for
issuance, and the Warrant Shares, when <FONT STYLE="background-color: white">issued, paid for and delivered upon due exercise of the Representative&rsquo;s
Warrant, will be duly authorized and validly issued, fully paid and nonassessable, </FONT>free and clear of all Liens. The Company has
sufficient authorized Ordinary Shares for the issuance of the maximum number of Securities issuable pursuant to the Offering as described
in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization</U>.
The capitalization of the Company is as set forth in the Registration Statement and the Prospectus. The Company has not issued any Ordinary
Shares since [Insert Date], other than (i) pursuant to the Company&rsquo;s equity incentive plans as described in the Registration Statement
and the Prospectus (the &ldquo;<B>Company Incentive Plans</B>&rdquo;), and (ii) the issuance of Ordinary Shares to employees, directors
or consultants pursuant to the Company Incentive Plans and pursuant to the conversion and/or exercise of any securities of the Company
or the Subsidiaries which would entitle the holder thereof to acquire Ordinary Shares at any time, including, without limitation, any
debt, preferred shares, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable
for, or otherwise entitles the holder thereof to receive, Ordinary Shares (&ldquo;<B>Ordinary Share Equivalents</B>&rdquo;) as described
in the Registration Statement and the Prospectus. No Person has any right of first refusal, preemptive right or right of participation,
or any similar right to participate in the transactions contemplated by this Agreement. Except as a result of the purchase and sale of
the Offered Securities or as disclosed in the Registration Statement and the Prospectus, there are no outstanding options, warrants, scrip
rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any Ordinary Shares or the capital
stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become
bound to issue additional Ordinary Shares or Ordinary Share Equivalents or capital stock of any Subsidiary. Except as disclosed in the
Registration statement or the Prospectus, the issuance and sale of the Offered Securities will not obligate the Company or any Subsidiary
to issue Ordinary Shares or other securities to any Person (other than the Underwriters) and will not result in a right of any holder
of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. Except as disclosed in
the Registration statement or the Prospectus, there are no securities of the Company or any Subsidiary that have any anti-dilution rights
(other than adjustments for stock splits, recapitalizations, and the like) to the exercise or conversion price, have any exchange rights,
or reset rights. Except as set forth in the Registration Statement, and the Prospectus, there are no outstanding securities or instruments
of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
The Company does not have any share appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement
relating to rights in Ordinary Shares. All of the outstanding Ordinary Shares are duly authorized, validly issued, fully paid and non-assessable,
have been issued in compliance in all material respects with all applicable securities laws, and none of such outstanding shares was issued
in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization
of any shareholder, the Board of Directors or others is required for the issuance and sale of the Offered Securities. Except as disclosed
in the Registration statement or the Prospectus, there are no shareholders agreements, voting agreements or other similar agreements with
respect to the Ordinary Shares or other securities of the Company to which the Company is a party or, to the knowledge of the Company,
between or among any of the Company&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the Registration Statement, except as specifically disclosed in the Registration Statement and the Prospectus, (i) there has been no event,
occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has
not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course
of business consistent with past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements
pursuant to International Financial Reporting Standards as issued by the International Accounting Standards Board (&ldquo;<B>IFRS</B>&rdquo;),
or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not
declared or made any dividend or distribution of cash or other property to its shareholders or purchased, redeemed or made any agreements
to purchase or redeem any Ordinary Shares and (v) the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company stock option plans, if any. The Company does not have pending before the Commission any request for
confidential treatment of information. Except for the issuance of the Offered Securities contemplated by the Prospectus or as disclosed
in the Registration Statement, any Preliminary Prospectus or the Prospectus, no event, liability, fact, circumstance, occurrence or development
has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective
business, prospects (as such prospects are described in the Prospectus), properties, operations, assets or financial condition that would
be required to be disclosed by the Company under the Securities Act, the Exchange Act or the Rules and Regulations as of the date of this
Agreement that has not been so disclosed under the Securities Act, the Exchange Act or the Rules and Regulations.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial
Statements</U>. The financial statements of the Company, together with the related notes and schedules, included in the Registration Statement,
any Preliminary Prospectus and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and
the Exchange Act and the Rules and Regulations, and fairly present, in all material respects, the financial condition of the Company as
of the dates indicated and the results of operations and changes in cash flows for the periods therein specified in conformity with IFRS
consistently applied throughout the periods involved. No other financial statements or schedules are required under the Securities Act,
the Exchange Act, or the Rules and Regulations to be included in the Registration Statement, any Preliminary Prospectus and the Prospectus.
The pro forma financial statements included in the Registration Statement, any Preliminary Prospectus and the Prospectus include assumptions
that provide a reasonable basis for presenting the significant effects directly attributable to the transactions and events described
therein, the related pro forma adjustments give appropriate effect to those assumptions, and the pro forma adjustments reflect the proper
application of those adjustments to the historical financial statements amounts in the pro forma financial statements included in the
Registration Statement, any Preliminary Prospectus and the Prospectus. The pro forma financial statements included in the Registration
Statement, any Preliminary Prospectus and the Prospectus comply as to form in all material respects with the application requirements
of Regulation S-X under the Exchange Act. No other pro forma financial information or schedules are required under the Securities Act,
the Exchange Act, or the rules and regulations thereunder to be included in the Registration Statement, any Preliminary Prospectus and
the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>.
Except as disclosed in the Registration Statement, any Preliminary Prospectus or the Prospectus, there is no action, suit, proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary, any of their
respective properties or any of the Company&rsquo;s officers or directors before or by any court, arbitrator, governmental or administrative
agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<B>Action</B>&rdquo;) which (i) adversely
affects or challenges the legality, validity or enforceability of this Agreement or any of the Transaction Documents or the Offering or
the Securities or (ii) could, if there were an unfavorable decision, reasonably be expected to result in a Material Adverse Effect. Neither
the Company nor any Subsidiary, nor any director or officer thereof, is or has within the last 10 years been the subject of any Action
involving an order, judgment, decree, or finding of violation of or liability under federal or state securities laws or a claim of breach
of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by
the Commission involving the Company or any current or former director or officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Labor
Relations</U>. No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the
Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that
their relationships with their employees are good. No executive officer, to the knowledge of the Company, is, or is now expected to be,
in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition
agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of
each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing
matters. The Company and its Subsidiaries are in compliance with all applicable laws and regulations relating to employment and employment
practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance</U>.
Except as set forth in the Registration Statement, any Preliminary Prospectus or the Prospectus , neither the Company nor any Subsidiary:
(i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both,
would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that
it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to
which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii)
is in violation of any judgment, decree or order of any court, arbitrator or governmental body or (iii) is or has been in violation of
any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and
local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and
labor matters, except in each case as could not reasonably be expected to result in a Material Adverse Effect.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the Prospectus, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<B>Material
Permits</B>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory
Matters</U>. The tests conducted by or on behalf of or sponsored by the Company or its Subsidiaries that are described or referred to
in the Registration Statement, any Preliminary Prospectus and the Prospectus were and, if still pending, are being conducted in accordance
in all material respects with all statutes, laws, rules and regulations, as applicable. Neither the Company nor its Subsidiaries has received
any notices or other correspondence from any foreign, federal, state or local governmental or regulatory authority with respect to any
ongoing tests requiring the termination or suspension of such tests. Except as would not be reasonably expected to result in a Material
Adverse Effect, neither the Company nor any of its Subsidiaries has failed to file with any foreign, federal, state or local governmental
or the applicable regulatory authorities any filing, declaration, listing, registration, report or submission that is required to be so
filed. All such filings were in material compliance with applicable laws when filed and no deficiencies have been asserted by any applicable
regulatory authority with respect to any such filings, declarations, listings, registrations, reports or submissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each
case free and clear of all Liens, except for Liens disclosed in the Registration Statement, any Preliminary Prospectus and the Prospectus,
Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made
of such property by the Company and the Subsidiaries and Liens for the payment of federal, state or other taxes, the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance except for
any breach that could not reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Patents
and Trademarks</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar
rights necessary or required for use in connection with their respective businesses as described in the Registration Statement or the
Prospectus and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<B>Intellectual Property Rights</B>&rdquo;).
None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property
Rights has expired, terminated or been abandoned, or is expected to expire or be abandoned, within two (2) years from the date of this
Agreement, except where such action would not reasonably be expected to have a Material Adverse Effect. Except as disclosed in the Registration
Statement or the Prospectus, neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements
included within the Registration Statement and the Prospectus, a written notice of a claim or otherwise has any knowledge that the Intellectual
Property Rights violate or infringe upon the rights of any Person, except as would not have or reasonably be expected to not have a Material
Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement
by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures
to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has no knowledge that it lacks or will be unable
to obtain any rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transactions
With Affiliates and Employees</U>. Except as set forth in the Registration Statement, any Preliminary Prospectus and the Prospectus, none
of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a
party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company,
any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner,
in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for
expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option
plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Undisclosed Contracts</U>. There is no contract or document required by the Securities Act or by the Rules and Regulations to be described
in the Registration Statement or in the Prospectus or to be filed as an exhibit to the Registration Statement which is not so described
or filed therein as required. All descriptions of any such contracts or documents contained in the Registration Statement, any Preliminary
Prospectus and in the Prospectus are accurate and complete descriptions of such documents in all material respects. Other than as described
in the Registration Statement and the Prospectus, no such contract has been suspended or terminated for convenience or default by the
Company or any Subsidiary party thereto or any of the other parties thereto, and neither the Company nor any of its Subsidiaries has received
notice, and the Company has no knowledge, of any such pending or threatened suspension or termination, except for suspensions or terminations
that are not reasonably likely to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Undisclosed Relationships</U>. No relationship, direct or indirect, exists between or among the Company or any of its Subsidiaries on
the one hand, and the directors, officers, shareholders (or analogous interest holders), customers or suppliers of the Company or any
of its Subsidiaries on the other hand, which is required to be described in or filed as an exhibit to the Registration Statement or the
Prospectus and which is not so described or filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Continued
Business</U>. No supplier, customer,&nbsp;distributor or sales agent of the Company or any Subsidiary has&nbsp;notified the Company or
any Subsidiary that it intends to&nbsp;discontinue or&nbsp;decrease the rate of business done&nbsp;with&nbsp;the Company or any Subsidiary,
except where such discontinuation or decrease has not resulted in and could not reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sarbanes-Oxley;
Accounting and Disclosure Controls</U>. Except as disclosed in the Registration Statement and in the Prospectus, the Company is in compliance
with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective and applicable to the Company as of the
date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date
hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide
reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii)
transactions are recorded as necessary to permit preparation of financial statements in conformity with IFRS and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and
reported, within the time periods specified in the Commission&rsquo;s rules and forms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Fees, FINRA Affiliation</U>. Except as set forth herein and in the Registration Statement and the Prospectus, no brokerage or finder&rsquo;s
fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement
agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. Except as set
forth in the Registration Statement, and the Prospectus, to the Company&rsquo;s knowledge, there are no other arrangements, agreements
or understandings of the Company or, to the Company&rsquo;s knowledge, any of its stockholders that may affect the Underwriters&rsquo;
compensation, as determined by FINRA. Except as already disclosed to the Representative, Company has not made any direct or indirect payments
(in cash, securities or otherwise) to (i) any person, as a finder&rsquo;s fee, investing fee or otherwise, in consideration of such person
raising capital for the Company or introducing to the Company persons who provided capital to the Company, (ii) any FINRA member, or (iii)
any person or entity that has any direct or indirect affiliation or association with any FINRA member within the 12-month period prior
to the date on which the Registration Statement was filed with the Commission (the &ldquo;<B>Filing Date</B>&rdquo;) or thereafter. To
the Company&rsquo;s knowledge, no (i) officer or director of the Company or its subsidiaries, (ii) owner of 10% or more of the Company&rsquo;s
unregistered securities or that of its subsidiaries or (iii) owner of any amount of the Company&rsquo;s unregistered securities acquired
within the 180-day period prior to the Filing Date, has any direct or indirect affiliation or association with any FINRA member. The Company
will advise the Representative if it becomes aware that any officer, director or stockholder of the Company or its Subsidiaries is or
becomes an affiliate or associated person of a FINRA member participating in the Offering.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Offered Securities, will
not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Rights</U>. No Person has any right to cause the Company to effect the registration under the Securities Act of any securities of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Offered Securities hereunder, the current cash flow of the Company, together with the proceeds the
Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, are sufficient
to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur
debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect
of its debt). Except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any facts or circumstances
which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction
within one year from the Closing Date. The Registration Statement and the Prospectus sets forth as of the date provided therein under
the &ldquo;Capitalization&rdquo; section all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which
the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<B>Indebtedness</B>&rdquo; means (x) any liabilities
for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business),
(y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or
should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable
instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease
payments in excess of $50,000 due under leases required to be capitalized in accordance with IFRS. Except as set forth in the Registration
Statement and the Prospectus, neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse
Effect, the Company and each Subsidiary (i) has made or filed all income and franchise tax returns, reports and declarations required
by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in
amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably
adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.
There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Auditors</U>.
WWC, P.C. (the &ldquo;<B>Auditor</B>&rdquo;) is the Company&rsquo;s independent registered public accounting firm. To the knowledge and
belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) has expressed
its opinion with respect to the financial statements of the Company and its subsidiaries for the periods filed with the Registration Statement
or the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Office
of Foreign Assets Control</U>. Neither the Company nor any of its Subsidiaries, nor, to the knowledge of the Company, any director or
officer of the Company or any Subsidiary, or any employee, representative, agent or affiliate of the Company or any of its Subsidiaries
or any other person acting on behalf of the Company or any of its Subsidiaries is currently subject to any U.S. sanctions administered
by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<B>OFAC</B>&rdquo;), and the Company will not directly
or indirectly use the proceeds of the offering of the Securities contemplated hereby, or lend, contribute or otherwise make available
such proceeds to any person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions
administered by OFAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>.
The Company and each of its Subsidiaries carries, or is covered by, insurance in such amounts and covering such risks as, in the Company&rsquo;s
reasonable belief, is adequate for the conduct of its business and the value of its properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Company
Not Ineligible Issuer</U>. (i) At the time of filing the Registration Statement relating to the Offered Securities and (ii) as of the
date of the execution and delivery of this Agreement (with such date being used as the determination date for purposes of this clause
(ii)), the Company met all the requirements set forth in General Instruction I of Form F-1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Emerging
Growth Company</U>. From the time of the initial confidential submission of the Registration Statement to the Commission (or, if earlier,
the first date on which the Company engaged directly or through any person authorized to act on its behalf in any Testing-the-Waters Communications)
through the date hereof, the Company has been and is an &ldquo;emerging growth company,&rdquo; as defined in Section 2(a) of the Securities
Act (an &ldquo;<B>Emerging Growth Company</B>&rdquo;). &ldquo;<B>Testing-the-Waters Communication</B>&rdquo; means any oral or written
communication with potential investors undertaken in reliance on Section 5(d) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Forward-Looking
Statements</U>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) contained in either the Registration Statement, any Preliminary Prospectus or the Prospectus has been made or reaffirmed without
a reasonable basis or has been disclosed other than in good faith.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Statistical
or Market-Related Data</U>. Any statistical, industry-related and market-related data included or incorporated by reference in the Registration
Statement, any Preliminary Prospectus or the Prospectus, are based on or derived from sources that the Company reasonably and in good
faith believes to be reliable and accurate, and such data agree with the sources from which they are derived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Listing
and Maintenance Requirements.&nbsp;</U>The Securities are registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Securities
under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing
and maintenance requirements. The Offered Securities are currently eligible for electronic transfer through the Depository Trust Company
or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such
other established clearing corporation) in connection with such electronic transfer. The issuance and sale of the Securities hereunder
does not contravene the rules and regulations of Nasdaq.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Foreign
Corrupt Practices</U>. Neither the Company, nor to the knowledge of the Company, any agent or other person acting on behalf of the Company,
has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to
foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to
any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the
Company (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any
material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulation
M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action
designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale
or resale of any of the Offered Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Offered Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Underwriters in connection with
the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>&nbsp;Testing
the Waters Communications</U>. The Company (a) has not alone engaged in any Testing-the-Waters Communication other than Testing-the-Waters
Communications with the consent of the Representative with entities that are qualified institutional buyers within the meaning of Rule
144A under the Securities Act or institutions that are accredited investors within the meaning of Rule 501 under the Securities Act and
(b) has not authorized anyone other than the Underwriters to engage in Testing-the-Waters Communications. The Company reconfirms that
the Underwriters have been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The Company has not distributed
any Written Testing-the-Waters Communications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<B>Money Laundering Laws</B>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certificates</U>.
Any certificate signed by an officer of the Company and delivered to the Underwriters or to counsel for the Underwriters shall be deemed
to be a representation and warranty by the Company to the Underwriters as to the matters set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reliance</U>.
The Company acknowledges that the Underwriters will rely upon the accuracy and truthfulness of the foregoing representations and warranties
and hereby consents to such reliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3. Delivery and
Payment</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
the basis of the representations, warranties and agreements herein contained, but subject to the terms and conditions herein set forth,
the Company agrees to issue and sell the Firm Shares to the Underwriters, and the Underwriters agree to purchase the Firm Shares. The
purchase price for each Firm Share shall be $4.00 per share (the &ldquo;<B>Per Share Price</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company hereby grants to the Representative the option to purchase some or all of the Option Shares, and, upon the basis of the warranties
and representations and subject to the terms and conditions herein set forth, the Underwriters shall have the right to purchase all or
any portion of the Option Shares at the Per Share Price as may be necessary to cover over-allotments made in connection with the transactions
contemplated hereby. This option may be exercised by the Representative at any time (but not more than once) on or before the forty-fifth
(45<SUP>th</SUP>) day following the date of the Prospectus, by written notice to the Company (the &ldquo;<B>Option Notice</B>&rdquo;).
The Option Notice shall set forth the aggregate number of Option Shares as to which the option is being exercised, and the date and time
when the Option Shares are to be delivered (such date and time being herein referred to as the &ldquo;<B>Option Closing Date</B>&rdquo;);
<I>provided, however</I>, that the Option Closing Date shall not be earlier than the Closing Date (as defined below) nor earlier than
the first business day after the date on which the option shall have been exercised nor later than the fifth business day after the date
on which the option shall have been exercised unless the Company and the Representative otherwise agree.&nbsp; Payment of the purchase
price for and delivery of the Option Shares shall be made at the Option Closing Date in the same manner and at the same office as the
payment for the Firm Shares as set forth in subparagraph (c) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Firm Shares will be delivered by the Company to the Representative against payment of the purchase price therefor by wire transfer of
same day funds payable to the order of the Company&rsquo;s offices, or such other location as may be mutually acceptable, at a mutually
agreeable time, on the second (or if the Firm Shares are priced, as contemplated by Rule 15c6-1(c) under the Exchange Act, after 4:30
p.m. Eastern Time, the third) full business day following the date hereof, or at such other time and date as the Representative and the
Company determine pursuant to Rule 15c6-1(a) under the Exchange Act, or, in the case of the Option Shares, at such date and time set forth
in the Option Notice. The time and date of delivery of the Firm Shares or the Option Shares, as applicable, is referred to herein as the
&ldquo;<B>Closing Date</B>.&rdquo; If the Representative so elects, delivery of the Firm Shares and Option Shares may be made by credit
through full fast transfer to the account at The Depository Trust Company designated by the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4. Covenants and
Agreements of the Company</B>. The Company further covenants and agrees with the Underwriters as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Statement Matters</U>. The Registration Statement and any amendments thereto have been declared effective, and if Rule 430A is used or
the filing of the Prospectus is otherwise required under Rule 424(b), the Company will file the Prospectus (properly completed if Rule
430A has been used) pursuant to Rule 424(b) within the prescribed time period and will provide evidence satisfactory to the Representative
of such timely filing. The Company will advise the Representative promptly after they receive notice thereof of the time when any amendment
to the Registration Statement has been filed or becomes effective or any supplement or amendment to the Prospectus has been filed and
will furnish the Representative with copies thereof. The Company will file promptly all reports and any definitive proxy or information
statements required to be filed by the Company with the Commission pursuant to Section 13(a), 14 or 15(d) of the Exchange Act subsequent
to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with the Offering. The Company
will advise the Representative promptly after it receives notice thereof (i) of any request by the Commission to amend the Registration
Statement or to amend or supplement the Prospectus or for additional information, and (ii) of the issuance by the Commission of any stop
order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or any order preventing or suspending
the use of the Prospectus or any amendment or supplement thereto or any post-effective amendment to the Registration Statement, of the
suspension of the qualification of the Offered Securities for offering or sale in any jurisdiction, of the institution or threatened institution
of any proceeding for any such purpose, or of any request by the Commission for the amending or supplementing of the Registration Statement,
any Preliminary Prospectus or the Prospectus or for additional information. The Company shall use its commercially reasonable efforts
to prevent the issuance of any such stop order or prevention or suspension of such use. If the Commission shall enter any such stop order
or order or notice of prevention or suspension at any time, the Company will use its commercially reasonable efforts to obtain the lifting
of such order at the earliest possible moment, or will file a new registration statement and use commercially reasonable efforts to have
such new registration statement declared effective as soon as practicable. Additionally, the Company agrees that it shall comply with
the provisions of Rules 424(b), 430A, 430B and 430C, as applicable, under the Securities Act, including with respect to the timely filing
of documents thereunder, and will use commercially reasonable efforts to confirm that any filings made by the Company under such Rule
424(b) are received in a timely manner by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Blue
Sky Compliance</U>. The Company will cooperate with the Representative in endeavoring to qualify the Offered Securities for sale under
the securities laws of such jurisdictions (United States and foreign) as the Representative may reasonably request and will make such
applications, file such documents, and furnish such information as may be reasonably required for that purpose; <I>provided&nbsp;</I>the
Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction
where it is not now so qualified or required to file such a consent; and&nbsp;<I>provided further</I>&nbsp;that the Company shall not
be required to produce any new disclosure document other than the Prospectus. The Company will, from time to time, prepare and file such
statements, reports and other documents as are or may be required to continue such qualifications in effect for so long a period as the
Representative may reasonably request for distribution of the Offered Securities. The Company will advise the Representative promptly
of the suspension of the qualification or registration of (or any such exemption relating to) the Offered Securities for offering, sale
or trading in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of
any order suspending such qualification, registration or exemption, the Company shall use its commercially reasonable efforts to obtain
the withdrawal thereof at the earliest possible moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments
and Supplements to the Prospectus and Other Matters</U>. The Company will comply with the Securities Act and the Exchange Act, and the
rules and regulations of the Commission thereunder, so as to permit the completion of the distribution of the Offered Securities as contemplated
in this Agreement and the Prospectus. If during the period in which a prospectus is required by law to be delivered in connection with
the distribution of Offered Securities contemplated by the Prospectus (the &ldquo;<B>Prospectus Delivery Period</B>&rdquo;), any event
shall occur as a result of which, in the judgment of the Company or in the opinion of the Representative or counsel for the Underwriters,
it becomes necessary to amend or supplement the Prospectus in order to make the statements therein, in the light of the circumstances
under which they were made, as the case may be, not misleading, or if it is necessary at any time to amend or supplement the Prospectus
to comply with any law, the Company will promptly prepare and file with the Commission, and furnish at its own expense to the Underwriters
and to any dealers, an appropriate amendment to the Registration Statement or supplement to the Registration Statement, any Preliminary
Prospectus or the Prospectus that is necessary in order to make the statements in the Prospectus as so amended or supplemented, in the
light of the circumstances under which they were made, as the case may be, not misleading, or so that the Registration Statement, any
Preliminary Prospectus or the Prospectus, as so amended or supplemented, will comply with law. Before amending the Registration Statement
or supplementing the Prospectus in connection with the Offering, the Company will furnish the Representative with a copy of such proposed
amendment or supplement and will not file any such amendment or supplement to which the Representative reasonably objects; the Representative
and its counsel shall have a reasonable amount of time to review and return any comments to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Copies
of any Amendments and Supplements to the Prospectus</U>. The Company will furnish the Underwriter, without charge, during the period beginning
on the date hereof and ending on the final Closing Date of the Offering, as many copies of the Prospectus and any amendments and supplements
thereto as the Representative may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Free
Writing Prospectus</U>. The Company covenants that it has not and will not, unless it has obtained or will obtain the prior consent of
the Representative, make any offer relating to the Offered Securities that would constitute a &ldquo;free writing prospectus&rdquo; (as
defined in Rule 405 of the Securities Act) required to be filed by the Company with the Commission or retained by the Company under Rule
433 of the Securities Act. In the event that the Representative expressly consents in writing to any such free writing prospectus (a &ldquo;<B>Permitted
Free Writing Prospectus</B>&rdquo;), the Company covenants that it shall (i) treat each Permitted Free Writing Prospectus as a Company
Free Writing Prospectus, and (ii) comply with the requirements of Rule 164 and 433 of the Securities Act applicable to such Permitted
Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration</U>.
The Company shall use commercially reasonable efforts to maintain the effectiveness of the Registration Statement and a current Prospectus
relating thereto for as long as the Securities remain outstanding. During any period when the Company fails to have maintained an effective
Registration Statement or a current Prospectus relating thereto and a holder of a Representative&rsquo;s Warrant desires to exercise such
warrants and, in the opinion of counsel to the holder, Rule 144 is not available as an exemption from registration for the resale of the
Warrant Shares, the Company shall promptly file a registration statement registering the resale of the Warrant Shares and use commercially
reasonable efforts to have it declared effective by the Commission within ninety (90) days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer
Agent</U>. The Company will maintain, at its expense, a registrar and transfer agent for its Ordinary Shares for so long as the Ordinary
Shares are publicly-traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Earnings
Statement</U>. As soon as practicable and in accordance with applicable requirements under the Securities Act, but in any event not later
than 18 months after the last Closing Date, the Company will make generally available to its security holders and to the Representative
an earnings statement, covering a period of at least 12 consecutive months beginning after the last Closing Date, that satisfies the provisions
of Section 11(a) and Rule 158 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Periodic
Reporting Obligations</U>. During the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the Commission all
reports and documents required to be filed under the Exchange Act within the time periods and in the manner required by the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Manipulation of Price</U>. The Company has not taken and will not take, directly or indirectly, any action designed to cause or result
in, or that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Company
Lock-Up</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will not, without the prior written consent of the Representative, from the date of execution of this Agreement and continuing
for a period of 12 months from the date on which the trading of the Ordinary Shares the Nasdaq commences (the &ldquo;<B>Lock-Up Period</B>&rdquo;):
(i) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option
or contract to sell, grant or change the terms of any option, right or warrant to purchase or otherwise transfer or dispose of, directly
or indirectly, or file with the Commission a registration statement under the Securities Act relating to, Ordinary Shares or Ordinary
Share Equivalents, or modify the terms of any existing securities, or (ii) enter into any swap or other agreement that transfers, in whole
or in part, any of the economic consequences of ownership of the Ordinary Shares or any Ordinary Share Equivalents, whether any such transaction
described in clause (i) or (ii) above is to be settled by delivery of Ordinary Shares or any Ordinary Share Equivalents, in cash or otherwise,
except to the Underwriters pursuant to this Agreement. The Company agrees not to accelerate the vesting of any option or warrant or the
lapse of any repurchase right prior to the expiration of the Lock-Up Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
restrictions contained in Section 4(k)(i) hereof shall not apply to: (A) the Offered Securities, (B) any Ordinary Shares previously issued
under Company Incentive Plans as described as outstanding in the Registration Statement and the Prospectus, (C) any options and other
awards granted under a Company Incentive Plan or Ordinary Shares issued pursuant to an employee stock purchase plan, in each case, as
described in the Registration Statement and the Prospectus, and (D) Ordinary Shares or other securities issued in connection with a transaction
with an unaffiliated third party that includes a bona fide commercial relationship (including joint ventures, marketing or distribution
arrangements, collaboration agreements or intellectual property license agreements) or any acquisition of assets or acquisition of not
less than a majority or controlling portion of the equity of another entity; provided that (x) the aggregate number of Ordinary Shares
issued pursuant to clause (D) shall not exceed five percent (5%) of the total number of outstanding Ordinary Shares immediately following
the issuance and sale of the Offered Securities pursuant to this Agreement and (y) the recipient of any such Ordinary Shares or other
securities issued or granted pursuant to clauses (B), (C) and (D) during the Lock-Up Period shall enter into an agreement substantially
in the form of <B><U>Exhibit A</U></B> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Acknowledgment</U>.
The Company acknowledges that any advice given by any of the Underwriters to the Company is solely for the benefit and use of the Board
of Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without such Underwriter&rsquo;s prior
written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5. Conditions of
the Obligations of the Underwriters</B>. The obligations of the Underwriters hereunder shall be subject to the accuracy of the representations
and warranties on the part of the Company set forth in Section 2 hereof, in each case as of the date hereof and as of the Closing Date
as though then made, to the timely performance by each of the Company of its covenants and other obligations hereunder on and as of such
dates, and to each of the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Accountants&rsquo;
Comfort Letter</U>. On the date hereof, the Representative shall have received, and the Company shall have caused to be delivered to the
Representative, a letter from the Auditor addressed to the Representative, dated as of the date hereof, in form and substance satisfactory
to the Representative. The letter shall not disclose any change in the condition (financial or other), earnings, operations, business
or prospects of the Company from that set forth in the Prospectus, which, in the Representative&rsquo;s sole judgment, is material and
adverse and that makes it, in the Representative&rsquo;s sole judgment, impracticable or inadvisable to proceed with the Offering of the
Offered Securities as contemplated by the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Bring-down
Comfort Letter</U>. On the Closing Date, the Representative shall have received from the Auditor a letter dated as of such Closing Date,
in form and substance satisfactory to the Representative, to the effect that they reaffirm the statements made in the letter furnished
pursuant to subsection (a) of this Section 5, except that the specified date referred to therein for the carrying out of procedures shall
be no more than three business days prior to such Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance
with Registration Requirements; No Stop Order; No Objection from FINRA</U>. The Registration Statement shall have become effective and
all necessary regulatory and listing approvals shall have been received not later than 5:30 P.M., New York City time, on the date of this
Agreement, or at such later time and date as shall have been consented to in writing by the Representative. The Prospectus (in accordance
with Rule 424(b)) and any Permitted Free Writing Prospectus shall have been duly filed with the Commission in a timely fashion in accordance
with the terms thereof. At or prior to the Closing Date and the actual time of the Closing, no stop order suspending the effectiveness
of the Registration Statement or any part thereof shall have been issued and no proceeding for that purpose shall have been initiated
or threatened by the Commission; no order preventing or suspending the use of the Prospectus shall have been issued and no proceeding
for that purpose shall have been initiated or threatened by the Commission; no order having the effect of ceasing or suspending the distribution
of the Offered Securities or any other securities of the Company shall have been issued by any securities commission, securities regulatory
authority or stock exchange and no proceedings for that purpose shall have been instituted or shall be pending or, to the knowledge of
the Company, contemplated by any securities commission, securities regulatory authority or stock exchange; all requests for additional
information on the part of the Commission shall have been complied with; and the FINRA shall have raised no objections to the fairness
and reasonableness of the placement terms and arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate
Proceedings</U>. All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement and the
Prospectus, and the registration, sale and delivery of the Offered Securities, shall have been completed or resolved in a manner reasonably
satisfactory to the Underwriters&rsquo; counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Material Adverse Effect</U>. Subsequent to the execution and delivery of this Agreement and prior to the Closing Date, in the Underwriter&rsquo;s
sole judgment after consultation with the Company, there shall not have occurred any Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Opinion
of Counsel for the Company</U>. The Representative shall have received on the Closing Date the favorable opinion and negative assurances
statement of Carmel, Milazzo &amp; Feil LLP, counsel to the Company, dated as of such Closing Date, including, without limitation, a customary
negative assurance letter, addressed to the Representative in customary form reasonably satisfactory to the Representative. The Underwriters
and Carmel, Milazzo &amp; Feil LLP, shall be entitled to rely on the opinion of each of the Company&rsquo;s British Virgin Islands and
Malaysian counsel filed as Exhibit 5.1 to the Registration Statement, as to the due incorporation, validity of the Securities and due
authorization, execution and delivery of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Opinion
of British Virgin Islands Counsel for the Company</U>. The Representative shall have received on the Closing Date the favorable opinion
of Carey Olsen (BVI) L.P., British Virgin Islands counsel to the Company, dated as of such Closing Date, including, without limitation,
a customary negative assurance letter, addressed to the Representative in customary form reasonably satisfactory to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Opinions
of Other Counsels for the Company&rsquo;s Subsidiaries</U>. The Representative shall have received on the Closing Date the favorable opinions
of each of Chooi &amp; Company and Cheang &amp; Ariff, the Company&rsquo;s Malaysian counsel, dated as of such Closing Date, for the Company&rsquo;s
subsidiaries, including, without limitation, a customary negative assurance letter, addressed to the Representative in customary form
reasonably satisfactory to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Officers&rsquo;
Certificate</U>. The Representative shall have received on the Closing Date a certificate of the Company, dated as of such Closing Date,
signed by the Chief Executive Officer and Chief Financial Officer of the Company, to the effect that, and the Representative shall be
satisfied that, the signers of such certificate have reviewed the Registration Statement and the Prospectus, and this Agreement and to
the further effect that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
representations and warranties of the Company in this Agreement are true and correct, as if made on and as of such Closing Date, and the
Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to
such Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
stop order suspending the effectiveness of the Registration Statement or the use of the Prospectus has been issued and no proceedings
for that purpose have been instituted or are pending or, to the Company&rsquo;s knowledge, threatened under the Securities Act; no order
having the effect of ceasing or suspending the distribution of the Offered Securities or any other securities of the Company has been
issued by any securities commission, securities regulatory authority or stock exchange in the United States and no proceedings for that
purpose have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities
regulatory authority or stock exchange in the United States;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsequent
to the respective dates as of which information is given in the Registration Statement and the Prospectus, there has not been: (a) any
Material Adverse Effect; (b) any transaction that is material to the Company and the Subsidiaries taken as a whole, except transactions
entered into in the ordinary course of business; (c) any obligation, direct or contingent, that is material to the Company and the Subsidiaries
taken as a whole, incurred by the Company or any Subsidiary, except obligations incurred in the ordinary course of business; (d) any material
change in the capital stock (except changes thereto resulting from the exercise of outstanding options or warrants or conversion of outstanding
indebtedness into Ordinary Shares) or outstanding indebtedness of the Company or any Subsidiary (except for the conversion of such indebtedness
into Ordinary Shares); (e) any dividend or distribution of any kind declared, paid or made on Ordinary Shares; or (f) any loss or damage
(whether or not insured) to the property of the Company or any Subsidiary which has been sustained or will have been sustained which has
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Secretary&rsquo;s
Certificate</U>. As of the Closing Date the Representative shall have received a certificate of the Company signed by the Secretary of
the Company, dated the Closing Date, certifying: (i) that each of the Company&rsquo;s articles of incorporation and bylaws attached to
such certificate is true and complete, has not been modified and is in full force and effect; (ii) that each of the Subsidiaries articles
of incorporation and bylaws or charter documents attached to such certificate is true and complete, has not been modified and is in full
force and effect; (iii) that the resolutions of the Company&rsquo;s Board of Directors relating to the Offering attached to such certificate
are in full force and effect and have not been modified; and (iv) the good standing of the Company and each of the Subsidiaries, but only
to the extent good standing is a concept applicable in the jurisdiction of formation of a Subsidiary. The documents referred to in such
certificate shall be attached to such certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional
Documents</U>. On or before the Closing Date, the Representative and counsel for the Underwriters shall have received such customary information
and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of the Offered Securities
as contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction of any
of the conditions or agreements, herein contained. If any condition specified in this Section 5 is not satisfied when and as required
to be satisfied, this Agreement may be terminated by the Representative by notice to the Company at any time on or prior to the Closing
Date, which termination shall be without liability on the part of any party to any other party, except that Section 6 (Payment of Expenses),
Section 7 (Indemnification and Contribution) and Section 8 (Representations and Indemnities to Survive Delivery) shall at all times be
effective and shall survive such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsequent
to the execution and delivery of this Agreement or, if earlier, the dates as of which information is given in the Registration Statement
(exclusive of any amendment thereof) and the Prospectus (exclusive of any supplement thereto), there shall not have been any change in
the capital stock or long-term debt of the Company (other than as described in the Registration Statement, any Preliminary Prospectus
or the Prospectus) or any change or development involving a change, whether or not arising from transactions in the ordinary course of
business, in the business, condition (financial or otherwise), results of operations, shareholders&rsquo; equity, properties or prospects
of the Company, taken as a whole, including but not limited to the occurrence of any fire, flood, storm, explosion, accident, act of war
or terrorism or other calamity, the effect of which, in any such case described above, is, in the sole judgment of the Representative,
so material and adverse as to make it impracticable or inadvisable to proceed with the sale of Offered Securities or Offering as contemplated
hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsequent
to the execution and delivery of this Agreement and up to a Closing Date, there shall not have occurred any of the following: (i) trading
in securities generally on the Nasdaq or any of the New York Stock Exchange, the NYSE American, or any tier of the markets operated by
OTC Markets Group, Inc. shall not have commenced, (ii) a banking moratorium shall have been declared by federal or state authorities or
a material disruption has occurred in commercial banking or securities settlement or clearance services in the United States, (iii) the
United States shall have become engaged in hostilities in which it is not currently engaged, the subject of an act of terrorism, there
shall have been an escalation in hostilities involving the United States, or there shall have been a declaration of a national emergency
or war by the United States, or (iv) there shall have occurred any other calamity or crisis or any actual or prospective change in general
economic, political or financial conditions in the United States or elsewhere, if the effect of any such event in clause (ii) or (iv)
makes it, in the sole judgment of the Representative, impracticable or inadvisable to proceed with the sale or delivery of the Offered
Securities on the terms and in the manner contemplated by the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Representative shall have received a lock-up agreement from each person or entity set forth on&nbsp;<U>Schedule A</U> (each, a &ldquo;<B>Lock-Up
Party</B>&rdquo;), duly executed by the applicable Lock-Up Party, in each case substantially in the form attached as&nbsp;<U>Schedule
B</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state
or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Offered Securities;
and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the
issuance or sale of the Offered Securities or materially and adversely affect or potentially materially and adversely affect the business
or operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any of the conditions specified
in this Section 5 shall not have been fulfilled when and as required by this Agreement, or if any of the certificates, opinions, written
statements or letters furnished to the Representative or to Underwriters&rsquo; counsel pursuant to this Section 5 shall not be reasonably
satisfactory in form and substance to the Representative and to Underwriters&rsquo; counsel, all obligations of the Underwriters hereunder
may be cancelled by the Representative at, or at any time prior to, the consummation of the Offering. Notice of such cancellation shall
be given to the Company in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6. Payment of Company
Expenses</B>. The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the performance of its
obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses incident
to the issuance, delivery and qualification of the Offered Securities (including all printing and engraving costs); (ii) all fees and
expenses of the registrar and transfer agent of the Offered Securities; (iii) all necessary issue, transfer and other stamp taxes in connection
with the issuance and sale of the Offered Securities; (iv) all fees and expenses of the Company&rsquo;s counsel, independent public or
certified public accountants and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing, filing,
shipping and distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates
of experts), the Prospectus, and all amendments and supplements thereto, and this Agreement; (vi) all filing fees, reasonable attorneys&rsquo;
fees and expenses incurred by the Company or the Underwriters in connection with qualifying or registering (or obtaining exemptions from
the qualification or registration of) all or any part of the Offered Securities for offer and sale under the state securities or blue
sky laws or the securities laws of any other country, and, if reasonably requested by the Representative, preparing and printing a &ldquo;Blue
Sky Survey,&rdquo; an &ldquo;International Blue Sky Survey&rdquo; or other memorandum, and any supplements thereto, advising any of the
Representative of such qualifications, registrations and exemptions; (vii) if applicable, the filing fees incident to the review and approval
by the FINRA of the Underwriters&rsquo; participation in the offering and distribution of the Offered Securities; (viii) the fees and
expenses associated with including the Offered Securities on the Nasdaq; and (ix) all costs and expenses incident to the travel and accommodation
of the Company&rsquo;s employees on the &ldquo;roadshow,&rdquo; as described in Section 1(a)(iv) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7. Indemnification
and Contribution</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to indemnify, defend and hold harmless the Underwriters, their respective affiliates, directors and officers and employees,
and each person, if any, who controls the Underwriters within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act (each an &ldquo;<B>Underwriter Indemnified Party</B>&rdquo;), from and against any losses, claims, damages or liabilities (including
in settlement of any litigation if such settlement is effected with the prior written consent of the Company) arising out of (i) an untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement, including the information deemed to
be a part of the Registration Statement at the time of effectiveness and at any subsequent time pursuant to Rules 430A and 430B of the
Securities Act Regulations, or arise out of or are based upon the omission from the Registration Statement, or alleged omission to state
therein, a material fact required to be stated therein or necessary to make the statements therein not misleading&#894; or (ii) an untrue
statement or alleged untrue statement of a material fact contained in the Prospectus, or any amendment or supplement thereto, or in any
other materials used in connection with the Offering, or arise out of or are based upon the omission or alleged omission to state therein
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading, and will reimburse such Underwriter Indemnified Party for any legal or other expenses reasonably incurred by
it in connection with evaluating, investigating or defending against such loss, claim, damage, liability or action&#894;&nbsp;<I>provided,
however</I>, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage, liability or action
arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration
Statement, the Prospectus, or any amendment or supplement thereto, or, in reliance upon and in conformity with the Underwriter Information.
The indemnification obligations under this&nbsp;<U>Section 7(a)&nbsp;</U>are not exclusive and will be in addition to any liability which
the Company might otherwise have and shall not limit any rights or remedies which may otherwise be available at law or in equity to each
Underwriter Indemnified Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Underwriters will indemnify, defend and hold harmless the Company, its affiliates, directors, officers and employees, and each person,
if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (each a &ldquo;<B>Company
Indemnified Party</B>&rdquo;), from and against any losses, claims, damages or liabilities to which such Company Indemnified Party may
become subject, under the Securities Act or otherwise (including in settlement of any litigation, if such settlement is effected with
the written consent of the Representative), insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise
out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the
Prospectus, or any amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein
a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent,
but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration
Statement, the Prospectus, or any amendment or supplement thereto, in reliance upon and in conformity with the Underwriter Information,
and will reimburse such Company Indemnified Party for any legal or other expenses reasonably incurred by it in connection with defending
against any such loss, claim, damage, liability or action. The indemnification obligations under this&nbsp;<U>Section 7(b)&nbsp;</U>are
not exclusive and will be in addition to any liability which the Underwriters might otherwise have and shall not limit any rights or remedies
which may otherwise be available at law or in equity to each Company Indemnified Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promptly
after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement of any action, such indemnified
party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the indemnifying
party in writing of the commencement thereof, but the failure to notify the indemnifying party shall not relieve the indemnifying party
from any liability that it may have to any indemnified party except to the extent such indemnifying party has been materially prejudiced
by such failure. In case any such action shall be brought against any indemnified party, and it shall notify the indemnifying party of
the commencement thereof, the indemnifying party shall be entitled to participate in, and, to the extent that it shall wish, jointly with
any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified
party, and after notice from the indemnifying party to such indemnified party of the indemnifying party&rsquo;s election so to assume
the defense thereof, the indemnifying party shall not be liable to such indemnified party under such subsection for any legal or other
expenses subsequently incurred by such indemnified party in connection with the defense thereof&#894; provided, however, that if (i) the
indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified
parties that are different from or in addition to those available to the indemnifying party, (ii) a conflict or potential conflict exists
(based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying
party will not have the right to direct the defense of such action on behalf of the indemnified party), or (iii) the indemnifying party
has not in fact employed counsel reasonably satisfactory to the indemnified party to assume the defense of such action within a reasonable
time after receiving notice of the commencement of the action, the indemnified party shall have the right to employ a single counsel to
represent it in any claim in respect of which indemnity may be sought under subsection (a) or (b) of this Section 7, in which event the
reasonable fees and expenses of such separate counsel shall be borne by the indemnifying party or parties and reimbursed to the indemnified
party as incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
indemnifying party under this Section 7 shall not be liable for any settlement of any proceeding effected without its written consent,
but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified
party against any loss, claim, damage, liability or expense by reason of such settlement or judgment. No indemnifying party shall, without
the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment in any pending
or threatened action, suit or proceeding in respect of which any indemnified party is a party or could be named and indemnity was or would
be sought hereunder by such indemnified party, unless such settlement, compromise or consent (i) includes an unconditional release of
such indemnified party from all liability for claims that are the subject matter of such action, suit or proceeding and (ii) does not
include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. Notwithstanding
the foregoing, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees
and expenses of counsel pursuant to Section 7(c), such indemnifying party agrees that it shall be liable for any settlement effected without
its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid
request and (ii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the
date of such settlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the indemnification provided for in this Section 7 is unavailable or insufficient to hold harmless an indemnified party under subsection
(a) or (b) above, then the indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of
the losses, claims, damages or liabilities referred to in subsection (a) or (b) above, (i) in such proportion as is appropriate to reflect
the relative benefits received by the Company on the one hand and the Underwriters on the other hand from the offering and sale of the
Securities or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate
to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company on the one hand and
the Underwriters on the other hand in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities,
as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters
on the other hand shall be deemed to be in the same proportion as the total net proceeds from the Offering (before deducting expenses)
received by the Company bear to the total cash fees received by the Underwriters. The relative fault shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company or the Underwriters and the parties&rsquo; relevant intent, knowledge,
access to information and opportunity to correct or prevent such untrue statement or omission. The Company and the Underwriters agree
that it would not be just and equitable if contributions pursuant to this subsection (e) were to be determined by pro rata allocation
(even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account
of the equitable considerations referred to in the first sentence of this subsection (e). The amount paid by an indemnified party as a
result of the losses, claims, damages or liabilities referred to in the first sentence of this subsection (e) shall be deemed to include
any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending against any action
or claim that is the subject of this subsection (e). No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this Agreement, the Representative confirms, and the Company acknowledges, that there is no information concerning the Underwriters
furnished in writing to the Company by the Underwriters specifically for preparation of or inclusion in the Registration Statement, any
Preliminary Prospectus or the Prospectus other than the Underwriter Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 8. Representations
and Indemnities to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and other statements of the
Company or any person controlling the Company, of its officers, and of the Underwriters set forth in or made pursuant to this Agreement
will remain in full force and effect, regardless of any investigation made by or on behalf of the Underwriters, the Company, or any of
its or their respective affiliates, officers or directors or any controlling person, as the case may be, and will survive delivery of
and payment for the Offered Securities sold hereunder and any termination of this Agreement. A successor to the Underwriters, or to the
Company, its directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution
and reimbursement agreements contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9. Termination.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement shall become effective upon the mutual execution of this Agreement by the Company and the Representative. The Representative
shall have the right to terminate this Agreement by giving written notice to the Company at any time prior to the Closing Date if: (i)
any domestic or international event or act or occurrence has materially disrupted, or in the reasonable opinion of the Representative
will in the immediate future materially disrupt, the market for the Company&rsquo;s securities or securities in general; or (ii) trading
on Nasdaq has been rejected by Nasdaq or made subject to material limitations, or minimum or maximum prices for trading have been fixed,
or maximum ranges for prices for securities have been required, on the Nasdaq or by order of the Commission, FINRA or any other governmental
authority having jurisdiction; or (iii) a banking moratorium has been declared by any state or federal authority or any material disruption
in commercial banking or securities settlement or clearance services has occurred; or (iv) (A) there has occurred any outbreak or escalation
of hostilities or acts of terrorism involving the United States, the British Virgin Islands or Malaysia or there is a declaration of a
national emergency or war by the United States, the British Virgin Islands or Malaysia or (B) there has been any other calamity or crisis
or any change in political, financial or economic conditions, if the effect of any such event in (A) or (B), in the reasonable judgment
of the Representative, is so material and adverse that such event makes it impracticable or inadvisable to proceed with the Offering,
sale and delivery of the Securities on the terms and in the manner contemplated by the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
notice of termination pursuant to this Section 9 shall be in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
this Agreement shall be terminated pursuant to any of the provisions hereof, or if the sale of the Securities provided for herein is not
consummated because any condition to the obligations of the Underwriters set forth herein is not satisfied or because of any refusal,
inability or failure on the part of the Company to perform any agreement herein or comply with any provision hereof, the Company will,
subject to demand by the Representative, reimburse the Underwriters for only the reasonable fees and expenses of their counsel actually
incurred by the Underwriters in connection herewith as allowed under FINRA Rule 5110, less any amounts previously paid by the Company,
subject to the cap on expenses set forth in Section 1(a)(iv) hereof. To the extent that the Underwriters&rsquo; out-of-pocket expenses
are less than the sums already advanced by the Company to the Underwriter (&ldquo;<B>Advances</B>&rdquo;), the Underwriters will return
to the Company that portion of the Advances not offset by actual expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10. </B><U>Right
of First Refusal</U><B>. </B>The Company hereby grants the Representative a right of first refusal (&ldquo;<B>Right of First Refusal</B>&rdquo;)
for two (2) years from the date of consummation of the Offering or the termination or expiration of the Company&rsquo;s engagement of
the Representative, to act as underwriter, placement agent or financial advisor in connection with any public or private financings in
the United States (debt or equity, and including self-underwritten offerings), merger, business combination, recapitalization or sale
of some or all of the equity or assets of the Company or any of its Subsidiaries out of the ordinary course of business, whether in conjunction
with another broker-dealer or on the Company&rsquo;s own volition, (collectively, &ldquo;<B>Future Services</B>&rdquo;); <I>provided,
however,</I> that the Representative shall not be entitled to have such Right of First Refusal if no Offering is consummated. The Company
shall notify the Representative in writing of its intention to pursue an activity that would enable the Representative to exercise its
Right of First Refusal to provide Future Services. In the event the Company notifies the Representative of its intention to pursue an
activity that would enable the Representative to exercise its Right of First Refusal to provide Future Services, the Representative shall
notify the Company of its election to provide such Future Services, including notification of the compensation and other terms to which
the Representative claims to be entitled, within thirty (30) days of written notice by the Company. In the event the Company engages the
Representative to provide such Future Services, the Representative will be compensated consistent with Section 2 of that certain engagement
letter between the Company and the Representative, dated January 19, 2022 (as amended, the &ldquo;<B>Engagement Letter</B>&rdquo;), unless
mutually agreed otherwise by the Company and the Representative. Representative shall be entitled to compensation under Section 2 of the
Engagement Letter in the event the Company conducts a Transaction as defined in the Engagement Letter and does not provide notice to Representative
of such Transaction pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 11. Notices</B>.
All communications hereunder shall be in writing and shall be mailed, hand delivered, delivered by reputable overnight courier (i.e.,
Federal Express) or delivered by facsimile or e-mail transmission to the parties hereto as follows:<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>If to the Representative, then to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Boustead Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt">6 Venture, Suite 395</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt">Irvine, CA 92618</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attn: Keith Moore</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email: keith@boustead1828.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>With a copy (which shall
not constitute notice) to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Sichenzia Ross Ference LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1185 6th Avenue, 31st Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">New York, NY 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Attn: Benjamin Tan, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Email: btan@srf.law</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>If to the Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">VCI Global Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">B03-C-8 Menara 3A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">KL Eco City, No. 3 Jalan Bangsar</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">59200 Kuala Lumpur,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Malaysia</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>With copies (which shall not constitute notice) to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Carmel, Milazzo &amp; Feil LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">55 West 39th Street, 4th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">New York, NY 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Attn: Ross D. Carmel, Esq./Jeffrey P. Wofford,
Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Email: rcarmel@cmfllp.com; jwofford@cmfllp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any party hereto may change
the address for receipt of communications by giving written notice to the others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 12. Successors</B>.
This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and
directors and controlling persons referred to in Section 7 hereof, and to their respective successors, and personal assigns, and no other
person will have any right or obligation hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 13. Partial Unenforceability</B>.
The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability
of any other section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for any reason determined
to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to
make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 14. Governing Law;
Venue; Agent for Service; Waiver of Jury Trial</B>. This Agreement shall be deemed to have been made and delivered in New York and both
this Agreement and the transactions contemplated hereby shall be governed as to validity, interpretation, construction, effect and in
all other respects by the internal laws of the State of New York, without regard to the conflict of laws principles thereof. Each of the
Underwriters and the Company: (i) agrees that any legal suit, action or proceeding arising out of or relating to this Agreement and/or
the transactions contemplated hereby shall be instituted exclusively in New York Supreme Court, County of New York, or in the United States
District Court for the Southern District of New York, (ii) waives any objection which it may now or hereafter have to the venue of any
such suit, action or proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New York,
and the United States District Court for the Southern District of New York in any such suit, action or proceeding. Each of the Underwriters
and the Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or
proceeding in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New
York and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s address shall be deemed in every
respect effective service of process upon the Company, in any such suit, action or proceeding, and service of process upon an Underwriter
mailed by certified mail to such Underwriter&rsquo;s address shall be deemed in every respect effective service process upon such Underwriter,
in any such suit, action or proceeding. The Company hereby appoints C T Corporation System, as its authorized agent (the &ldquo;<B>Authorized
Agent</B>&rdquo;) upon whom process may be served in any suit, action or proceeding arising out of or based upon the Transaction Documents
or the transactions contemplated herein which may be instituted in any court referred to above. The Company hereby represents and warrants
that the Authorized Agent (i) is validly existing and can lawfully accept such services of process and (ii) has accepted such appointment
and has agreed to act as said agent for service of process, and the Company agrees to take any and all action, including the filing of
any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. The Company hereby authorizes
and directs the Authorized Agent to accept such service. Service of process upon the Authorized Agent shall be deemed, in every respect,
effective service of process upon the Company. If the Authorized Agent shall cease to act as agent for service of process, the Company
shall appoint, without unreasonable delay, another such agent in the United States, and notify the Representative of such appointment.
This paragraph shall survive any termination of this Agreement, in whole or in part. The Company agrees that a final judgment in any such
action, proceeding or counterclaim brought in any such court shall be conclusive and binding upon the Company and may be enforced in any
other courts to the jurisdiction of which the Company is or may be subject, by suit upon such judgment. <B>EACH PARTY HEREBY IRREVOCABLY
WAIVES ANY RIGHT IT MAY HAVE AND AGREES NOT TO REQUEST A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE ARISING OUT OF OR RELATING TO
THIS AGREEMENT. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 15. General Provisions</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations solely with respect to the subject matters hereof. Notwithstanding anything to the contrary
set forth herein, it is understood and agreed by the parties hereto that all other terms and conditions of the Engagement Letter shall
remain in full force and effect. This Agreement may be executed in two or more counterparts, each one of which shall be an original, with
the same effect as if the signatures thereto and hereto were upon the same instrument. Such counterparts may be executed and delivered
by electronic means, which shall not impair such execution or delivery. This Agreement may not be amended or modified unless in writing
and signed by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party
whom the condition is meant to benefit. Section headings herein are for the convenience of the parties only and shall not affect the construction
or interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company acknowledges and agrees that in connection with the Offering of the Securities: (i) the Underwriters have acted at arm&rsquo;s
length, is not an agent of, and owes no fiduciary duties to the Company or any other person, (ii) the Underwriters owe the Company only
those duties and obligations set forth in this Agreement and (iii) the Underwriters may have interests that differ from those of the Company.
The Company waives to the full extent permitted by applicable law any claims it may have against the Underwriters arising from an alleged
breach of fiduciary duty in connection with the offering of the Offered Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>The remainder of this page has been intentionally
left blank</I>.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing is in accordance
with your understanding of our agreement, please sign below whereupon this instrument, along with all counterparts hereof, shall become
a binding agreement in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>VCI GLOBAL LIMITED</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name: Victor Hoo</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title: Chairman and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing Underwriting Agreement is hereby
confirmed and agreed to of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>BOUSTEAD SECURITIES, LLC</B>, in its </FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">own capacity and as representative of the Underwriters</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name: Keith Moore</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-weight: bold; border-bottom: Black 1pt solid">Name</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Firm Shares to be<BR>
 Purchased</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Option Shares to<BR>
be Purchased if the Over-<BR>
Allotment Option is Fully<BR>
 Exercised</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left">Boustead Securities, LLC</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">1,280,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">192,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,280,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">192,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Lock-up Parties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>12 Month Lockups</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>Hoo Voon Him</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>Liew Soo Hua</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>Hong Khay Kuan</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>Khoo Ter Kern@Stanley Khoo</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>Yong Hui Wun</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">6.</TD><TD>Enyoo Hoeng Wei</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">7.</TD><TD>Liu Ser Wei</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">8.</TD><TD>Asagsaham Sdn Bhd</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">9.</TD><TD>Wu Yun</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">10.</TD><TD>Yeo Khee Seng Benny</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">11.</TD><TD>V Invesco Fund (L) Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">12.</TD><TD>Exchange Listing LLC</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>6 Month Lockups</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>Acton Burnell Sdn Bhd</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>Lee Gin Chow</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>Eng Joe Yeow</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>Hee Ho Hin</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>Sim Ying Fai</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">6.</TD><TD>Teoh Ming Hong</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">7.</TD><TD>Ling Weng Tai</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">8.</TD><TD>Trenton Lim Zhen Tjen</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">9.</TD><TD>Lay Chin Moey</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">10.</TD><TD>Er Song Ngueng</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">11.</TD><TD>Anthony Hamdani</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">12.</TD><TD>Six Plus One Sdn Bhd</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">13.</TD><TD>Tan Ee Wei</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">14.</TD><TD>Ramssol Group Berhad</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">15.</TD><TD>Low Kok King</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">16.</TD><TD>Kong Hock Leng</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">17.</TD><TD>Low Siew Peng</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">18.</TD><TD>Mot Kam Wai</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">19.</TD><TD>Loh Jaw Hann</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">20.</TD><TD>Lee Teck Leong</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">21.</TD><TD>Yong Lee Lien</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">22.</TD><TD>Yong Meng Loh</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">23.</TD><TD>David Thomas Eager</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">24.</TD><TD>Gerard John Warrener</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">25.</TD><TD>Tan Chee Seng</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">26.</TD><TD>KC Workplace Sdn Bhd</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">27.</TD><TD>Foo Moong Nah</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">28.</TD><TD>Soo Chee Lap</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">29.</TD><TD>Wong Chun Sin</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">30.</TD><TD>Toh Ah Wah</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">31.</TD><TD>Ng Leong Yik</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">32.</TD><TD>Pua Kim An</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">33.</TD><TD>Chan Kin Keong</TD></TR></TABLE>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Lock-up Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[_____________], 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boustead Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6 Venture, Suite 395</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Irvine, CA 92618</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Re:&nbsp;<U>Proposed Public Offering by VCI Global Limited</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned, a shareholder
of VCI Global Limited, a British Virgin Islands company (the &ldquo;<U>Company</U>&rdquo;), understands that Boustead Securities, LLC
(the &ldquo;<U>Representative</U>&rdquo;) will act as the representative of the underwriters in carrying out an offering (the &ldquo;<U>Offering</U>&rdquo;)
of the Company&rsquo;s ordinary shares (the &ldquo;<U>Securities</U>&rdquo;). In recognition of the benefit that the Offering will confer
upon the undersigned, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
undersigned agrees with the Representative that, without the prior written consent of the Representative, during a period of up to 365
days from the date on which the trading of the Securities on the Nasdaq Stock Exchange commences (the &ldquo;<U>Lock-Up Period</U>&rdquo;),
the undersigned will not, without the prior written consent of the Representative, directly or indirectly (i) offer, pledge, sell, contract
to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase
or otherwise transfer or dispose of any securities of the Company (collectively, the &ldquo;<U>Lock-Up Securities</U>&rdquo;), whether
now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition,
or file, or cause to be filed, any registration statement under the Securities Act of 1933, as amended, with respect to any of the foregoing
or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the
economic consequence of ownership of the Lock-Up Securities, whether any such swap or transaction described in clause (i) or (ii) above
is to be settled by delivery of the Lock-Up Securities or such other securities, in cash or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Representative may in
its sole discretion and at any time without notice release some or all of the shares subject to lock-up agreements prior to the expiration
of the Lock-Up Period. When determining whether or not to release shares from the lock-up agreements, the Representative will consider,
among other factors, the security holder&rsquo;s reasons for requesting the release, the number of shares for which the release is being
requested and market conditions at the time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
and subject to the conditions below, the undersigned may transfer the Lock-Up Securities without the prior written consent of the Representative
as follows, provided that (1) the Representative receives a signed lock-up agreement for the balance of the Lock-Up Period from each donee,
trustee or transferee, as the case may be, (2) any such transfer shall not involve a disposition for value, (3) such transfers are not
required to be reported in any public report or filing with the Securities and Exchange Commission, or otherwise and (4) the undersigned
does not otherwise voluntarily effect any public filing or report regarding such transfers:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) as a bona fide gift or gifts
(including but not limited to charitable gifts); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) to any member of the immediate
family of the undersigned or to a trust or other entity for the direct or indirect benefit of, or wholly-owned by, the undersigned or
the immediate family of the undersigned (for purposes of this lock-up agreement, &ldquo;<U>immediate family</U>&rdquo; shall mean any
relationship by blood, marriage or adoption, not more remote than first cousin); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) if the undersigned is
a corporation, partnership, limited liability company, trust or other business entity (1) transfers to another corporation, partnership,
limited liability company, trust or other business entity that is a direct or indirect affiliate (as defined in Rule 405 promulgated under
the Securities Act of 1933, as amended) of the undersigned or (2) distributions of Ordinary Shares or any security convertible into or
exercisable for Ordinary Shares to limited partners, limited liability company members or stockholders of the undersigned; or&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv) if the undersigned is a
trust, transfers to the beneficiary of such trust; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v) by will, other testamentary
document or intestate succession; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vi) by operation of law pursuant
to a qualified domestic order or in connection with a divorce settlement.; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vii) pursuant to a trading
plan established pursuant to Rule 10b5-1 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, no provision
in this letter shall be deemed to restrict or prohibit (1) transactions relating to Securities purchased in the Offering or acquired in
open market transactions after the completion of Offering; and (2) the exercise or exchange by the undersigned of any option or warrant
to acquire any Ordinary Shares or options to purchase Ordinary Shares, in each case for cash or on a &ldquo;cashless&rdquo; or &ldquo;net
exercise&rdquo; basis, pursuant to any share option, share bonus or other share plan or arrangement; provided, however, that the underlying
Ordinary Shares shall continue to be subject to the restrictions on transfer set forth in this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned further agrees
that, prior to engaging in any transaction or taking any other action that is subject to the terms of this lock-up agreement during the
Lock-Up Period, it will give notice thereof to the Representative and will not consummate such transaction or take any such action unless
it has received written confirmation from the Company that the Lock-Up Period has expired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that, if the Offering shall terminate or be terminated prior to payment for and delivery of the Securities, the undersigned shall be released
from all obligations set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned also agrees
and consents to the entry of stop transfer instructions with the Company&rsquo;s transfer agent and registrar against the transfer of
the Lock-Up Securities except in compliance with the foregoing restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned, whether or
not participating in the Offering, understands that the Representative is proceeding with the Offering in reliance upon this lock-up agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This lock-up agreement shall
be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Name - Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Signature)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page to Lock-Up Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Representative&rsquo;s Warrant</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THE REGISTERED HOLDER OF THIS PURCHASE WARRANT
BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED
HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD
OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE EFFECTIVE DATE OF THE REGISTRATION STATEMENT TO ANYONE OTHER THAN (I) BOUSTEAD SECURITIES,
LLC, OR A REPRESENTATIVE OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF BOUSTEAD SECURITIES,
LLC, OR OF ANY SUCH UNDERWRITERS OR SELECTED DEALER.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR
TO___, 2023. VOID AFTER 5:00 P.M., EASTERN TIME, _____, 2028.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDERWRITER&rsquo;S WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE PURCHASE OF [&#9679;] ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VCI GLOBAL LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1. <U>Purchase Warrant</U>. THIS CERTIFIES THAT,
pursuant to that certain Underwriting Agreement by and between VCI Global Limited, a British Virgin Islands company (the &ldquo;<B>Company</B>&rdquo;),
on one hand, and Boustead Securities, LLC (the &ldquo;<B>Holder</B>&rdquo;), on the other hand, dated April 13, 2023 (the &ldquo;<B>Underwriting
Agreement</B>&rdquo;), the Holder, as registered owner of this Purchase Warrant, is entitled, at any time or from time to time from ___,
2023 (the &ldquo;<B>Exercise Date</B>&rdquo;), and at or before 5:00 p.m., Eastern time, on ____, 2028 (the &ldquo;<B>Expiration Date</B>&rdquo;,
which date shall be no more than five years from the commencement of sales of the initial public offering pursuant to the Underwriting
Agreement), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to _____ordinary shares (the &ldquo;<B>Shares</B>&rdquo;)
of the Company, no par value per ordinary share (the &ldquo;<B>Ordinary Shares</B>&rdquo;), subject to adjustment as provided in&nbsp;<U>Section
6</U>&nbsp;hereof. If the Expiration Date is a day on which banking institutions are authorized by law or executive order to close, then
this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During
the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase
Warrant is initially exercisable at $___ per Ordinary Share (100% of Offering price);&nbsp;<I>provided, however,</I>&nbsp;that upon the
occurrence of any of the events specified in&nbsp;<U>Section 6</U>&nbsp;hereof, the rights granted by this Purchase Warrant, including
the exercise price per Ordinary Share and the number of Ordinary Shares to be received upon such exercise, shall be adjusted as therein
specified. The term &ldquo;<B>Exercise Price</B>&rdquo; shall mean the initial exercise price as set forth above or the adjusted exercise
price as a result of the events set forth in Section 6 below, depending on the context. Capitalized terms not defined herein shall have
the meaning ascribed to them in the Underwriting Agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 <U>Exercise Form</U>.
In order to exercise this Purchase Warrant, the exercise form attached hereto as&nbsp;<U>Exhibit A</U>&nbsp;must be duly executed and
completed and delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Ordinary Shares
being purchased payable in cash by wire transfer of immediately available funds to an account designated by the Company or by certified
check. If the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration Date,
this Purchase Warrant shall become and be void without further force or effect, and all rights represented hereby shall cease and expire.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2 <U>Cashless Exercise</U>.
This Purchase Warrant may be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder
shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: -27pt">(A) = the Fair Market
Value of one Ordinary Share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B) = the Exercise Price of
this Purchase Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-align: justify; text-indent: -22.5pt">(X) = the number
of Ordinary Shares underlying the Purchase Warrant that would be issuable upon exercise of this Purchase Warrant in accordance with the
terms of this Purchase Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Shares are issued in such
a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Shares shall
take on the registered characteristics of the Purchase Warrants being exercised. The Company agrees not to take any position contrary
to this Section 2.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything herein
to the contrary, on the Expiration Date, this Purchase Warrant shall be automatically exercised via cashless exercise pursuant to this
Section 2.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Fair Market Value&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the common stock is then listed or
quoted on a Trading Market, the value shall be deemed to be the highest intra-day or closing price on any trading day on such Trading
Market on which the common stock is then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)) during the five trading days preceding the exercise, (b) if OTCQB or OTCQX is not an Trading
Market, the value shall be deemed to be the highest intra-day or closing price on any trading day on the OTCQB or OTCQX on which the common
stock is then quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York
City time)) during the five trading days preceding the exercise, as applicable, (c) if the common stock is not then listed or quoted for
trading on OTCQB or OTCQX and if prices for the common stock are then reported in the &ldquo;Pink Sheets&rdquo; published by OTC Markets
Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the &ldquo;OTC Markets Group&rdquo;,
the value shall be deemed to be the highest intra-day or closing price on any trading day on the Pink Sheets on which the common stock
is then quoted as reported by OTC Markets Group (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City
time)) during the five trading days preceding the exercise, or (d) in all other cases, the fair market value of a share of common stock
as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Trading Market&rdquo;
means the NASDAQ Stock Market LLC, or any of the following other markets or exchanges on which the Ordinary Shares are listed or quoted
for trading on the date in question: the NYSE American, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon a cashless exercise of
this Purchase Warrant pursuant to this Section 2.2 the Ordinary Shares to be issued to Holder shall be paid up out of any of the Company's
freely distributable reserves, other than share premium reserves maintained by the Company for the benefit of holders of preferred shares,
or out of any of the Company's statutory reserves which may be converted into share capital, to be determined by the Company's board of
directors in its sole discretion. A cashless exercise of this Purchase Warrant pursuant to this Section 2.2 shall only be permitted to
the extent the Company has sufficient freely distributable reserves, other than share premium reserves maintained by the Company for the
benefit of holders of preferred shares, or reserves which may be converted into share capital.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3 <U>Legend</U>. Each certificate
for the securities purchased under this Purchase Warrant shall bear the following legends unless such securities have been registered
under the Securities Act of 1933, as amended (the &ldquo;<B>Act</B>&rdquo;), or are exempt from registration under the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(i) &ldquo;THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;ACT&rdquo;), OR APPLICABLE STATE
LAW. NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED FOR SALE, SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW WHICH, IN THE
OPINION OF COUNSEL TO THE COMPANY, IS AVAILABLE.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(ii) Any legend required by the securities
laws of any state to the extent such laws are applicable to the Shares represented by a certificate, instrument, or book entry so legended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3. <U>Transfer</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>General Restrictions</U>.
The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder will not: (a) sell, transfer,
assign, pledge or hypothecate this Purchase Warrant (or any Shares issuable upon the exercise of this Purchase Warrant) for a period of
one hundred eighty (180) days following the effective date of the Registration Statement (the &ldquo;<B>Effective Date</B>&rdquo;) to
anyone other than: (i) the Underwriter or a selected dealer participating in the Offering, or (ii) a bona fide officer or partner of the
Underwriter or of any such selected dealer, in each case in accordance with FINRA Conduct Rule 5110(e)(1), or (b) cause this Purchase
Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative, put or call transaction that would
result in the effective economic disposition of this Purchase Warrant or the securities hereunder, except as provided for in FINRA Rule
5110(e)(2). On and after that date that is one hundred eighty (180) days after the Effective Date, transfers to others may be made subject
to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder must deliver to
the Company the assignment form attached hereto as&nbsp;<U>Exhibit B</U>&nbsp;duly executed and completed, together with this Purchase
Warrant and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five (5) Business Days transfer
this Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase Warrant or Purchase Warrants of like tenor
to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Ordinary Shares purchasable hereunder
or such portion of such number as shall be contemplated by any such assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Restrictions Imposed
by the Act</U>. The securities evidenced by this Purchase Warrant shall not be transferred unless and until: (i) the Company has received
the opinion of counsel for the Company that the securities may be transferred pursuant to an exemption from registration under the Act
and applicable state securities laws, the availability of which is established to the reasonable satisfaction of the Company, (ii) a registration
statement or a post-effective amendment to the registration statement relating to the offer and sale of such securities that has been
declared effective by the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) and includes a current prospectus
or (iii) a registration statement, pursuant to which the Holder has exercised its registration rights pursuant to&nbsp;<U>Section 4.1
</U>herein, relating to the offer and sale of such securities has been filed and declared effective by the Commission and compliance with
applicable state securities law has been established.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4. <U>Registration Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 &ldquo;<U>Piggy-Back&rdquo;
Registration</U>. At any time after 180 days from the date hereof that all of the Shares may not be resold by the Holder pursuant to an
exemption from registration under the Securities Act upon exercise on a cashless basis and unless all of the Ordinary Shares underlying
the Purchase Warrant (collectively, the &ldquo;<B>Registrable Securities</B>&rdquo;) are included in an effective registration statement
with a current prospectus, the Holder shall have the right, until the Expiration Date, or the maximum time allowable under FINRA Rule
5110(g)(8), whichever is the earlier, to include the remaining Registrable Securities as part of any other registration of securities
filed by the Company (other than in connection with a transaction contemplated by Rule 145 promulgated under the Act or pursuant to Forms
S-8, F-3, F-4 or any equivalent forms);&nbsp;<I>provided, however</I>, that if, solely in connection with any primary underwritten public
offering for the account of the Company, the managing underwriter(s) thereof shall, in its reasonable discretion, impose a limitation
on the number of Registrable Securities which may be included in the registration statement because, in such underwriter(s)&rsquo; judgment,
marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall be obligated
to include in such registration statement only such limited portion of the Registrable Securities with respect to which the Holder requested
inclusion hereunder as the underwriter shall reasonably permit; and&nbsp;<I>further provided</I>&nbsp;that no such piggy-back rights shall
exist for so long as the Registrable Securities (which term shall include those paid as consideration pursuant to the cashless exercise
provisions of this Purchase Warrant) may be sold pursuant to Rule 144 of the Act without restriction. Any exclusion of Registrable Securities
shall be made pro rata among the Holders seeking to include Registrable Securities in proportion to the number of Registrable Securities
sought to be included by such Holders;&nbsp;<I>provided, however</I>, that the Company shall not exclude any Registrable Securities unless
the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such
registration statement or are not entitled to pro rata inclusion with the Registrable Securities. In the event of such a proposed registration,
the Company shall furnish the then Holders of outstanding Registrable Securities with not less than fifteen (15) days written notice prior
to the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration
statement filed by the Company until such time as all of the Registrable Securities have been sold by the Holder. The Holders of the Registrable
Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein by giving written notice, within seven (7) days of the
receipt of the Company&rsquo;s notice of its intention to file a registration statement. Except as otherwise provided in this Purchase
Warrant, there shall be no limit on the number of times the Holder may request registration under this&nbsp;<U>Section 4.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>General Terms</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2.1 <U>Expenses of Registration</U>.
The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 4 hereof, but the
Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent them
in connection with the sale of the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2.2 <U>Indemnification</U>.
The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder and
each person, if any, who controls such Holders within the meaning of Section 15 of the Act or Section 20 (a) of the Securities Exchange
Act of 1934, as amended (&ldquo;<B>Exchange Act</B>&rdquo;), against all loss, claim, damage, expense or liability (including all reasonable
attorneys&rsquo; fees and other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to
which any of them may become subject under the Act, the Exchange Act or otherwise, arising from such registration statement but only to
the same extent and with the same effect as the provisions pursuant to which the Company has agreed to indemnify the Underwriter contained
in Section 5 of the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2.3 <U>Exercise of Purchase
Warrant</U>. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s) to exercise their Purchase Warrant
prior to or after the initial filing of any registration statement or the effectiveness thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2.4 <U>Documents to be Delivered
by Holder(s).</U>&nbsp;Each of the Holder(s) participating in any registration statement filed by the Company shall furnish to the Company
a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2.5 <U>Damages</U>. Should
the registration or the effectiveness thereof required by&nbsp;<U>Section 4</U>&nbsp;hereof be delayed by the Company or the Company otherwise
fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available to the Holder(s),
be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened breach of such provisions
or the continuation of any such breach, without the necessity of proving actual damages and without the necessity of posting bond or other
security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5. <U>New Purchase Warrants to be Issued</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 <U>Partial Exercise or
Transfer</U>. Subject to the restrictions in&nbsp;<U>Section 3</U>&nbsp;hereof, this Purchase Warrant may be exercised or assigned in
whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant for cancellation,
together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax if exercised
pursuant to&nbsp;<U>Section 2.1</U>&nbsp;hereof, the Company shall cause to be delivered to the Holder without charge a new Purchase Warrant
of like tenor to this Purchase Warrant in the name of the Holder evidencing the right of the Holder to purchase the number of Ordinary
Shares purchasable hereunder as to which this Purchase Warrant has not been exercised or assigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Lost Certificate</U>.
Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Purchase Warrant and
of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase Warrant of like
tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft, mutilation or destruction shall
constitute a substitute contractual obligation on the part of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6. <U>Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.1 <U>Adjustments to Exercise
Price and Number of Ordinary Shares</U>. The Exercise Price and the number of Ordinary Shares underlying this Purchase Warrant shall be
subject to adjustment from time to time as hereinafter set forth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.1 <U>Share Dividends; Split
Ups</U>. If, after the date hereof, and subject to the provisions of&nbsp;<U>Section 6.3</U>&nbsp;below, the number of outstanding Ordinary
Shares is increased by a stock dividend payable in Ordinary Shares or by a split up of Ordinary Shares or other similar event, then, on
the effective day thereof, the number of Ordinary Shares purchasable hereunder shall be increased in proportion to such increase in outstanding
Ordinary Shares, and the Exercise Price shall be proportionately decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.2 <U>Aggregation of Ordinary
Shares</U>. If, after the date hereof, and subject to the provisions of&nbsp;<U>Section 6.3</U>&nbsp;below, the number of outstanding
Ordinary Shares is decreased by a consolidation, combination or reclassification of Ordinary Shares or other similar event, then, on the
effective date thereof, the number of Ordinary Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding
Ordinary Shares, and the Exercise Price shall be proportionately increased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.3 <U>Replacement of Ordinary
Shares upon Reorganization, etc</U>. In case of any reclassification or reorganization of the outstanding Ordinary Shares other than a
change covered by&nbsp;<U>Section 6.1.1</U>&nbsp;or&nbsp;<U>Section 6.1.2</U>&nbsp;hereof or that solely affects the par value of such
Ordinary Shares, or in the case of any share reconstruction or amalgamation or consolidation of the Company with or into another corporation
(other than a consolidation or share reconstruction or amalgamation in which the Company is the continuing corporation and that does not
result in any reclassification or reorganization of the outstanding Ordinary Shares), or in the case of any sale or conveyance to another
corporation or entity of the property of the Company as an entirety or substantially as an entirety in connection with which the Company
is dissolved, the Holder of this Purchase Warrant shall have the right thereafter (until the expiration of the right of exercise of this
Purchase Warrant) to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder immediately prior to such
event, the kind and amount of ordinary shares or other securities or property (including cash) receivable upon such reclassification,
reorganization, share reconstruction or amalgamation, or consolidation, or upon a dissolution following any such sale or transfer, by
a Holder of the number of Ordinary Shares of the Company obtainable upon exercise of this Purchase Warrant immediately prior to such event;
and if any reclassification also results in a change in Ordinary Shares covered by&nbsp;<U>Section 6.1.1</U>&nbsp;or&nbsp;<U>Section 6.1.2</U>,
then such adjustment shall be made pursuant to&nbsp;<U>Section 6.1.1</U>,&nbsp;<U>Section 6.1.2</U>&nbsp;and this&nbsp;<U>Section 6.1.3</U>.
The provisions of this&nbsp;<U>Section 6.1.3&nbsp;</U>shall similarly apply to successive reclassifications, reorganizations, share reconstructions
or amalgamations, or consolidations, sales or other transfers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.4 <U>Fundamental
Transaction.</U>&nbsp;If, at any time while this Purchase Warrant is outstanding, (i) the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any direct or indirect purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Ordinary Shares are permitted to sell, tender or exchange their shares for
other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Ordinary Shares, (iv) the Company,
directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Ordinary
Shares or any compulsory share exchange pursuant to which the Ordinary Shares are effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spinoff or scheme of arrangement)
with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding Ordinary Shares (not
including any Ordinary Shares held by the other Person or other Persons making or party to, or associated or affiliated with, the other
Persons making or party to such stock or share purchase agreement or other business combination) (each a &quot;<B>Fundamental Transaction</B>&quot;),
then, upon any subsequent exercise of this Purchase Warrant, the Holder shall have the right to receive, for each Ordinary Share that
would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, the number of Ordinary
Shares of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional or alternative
consideration (the &quot;<B>Alternative Consideration</B>&quot;) receivable as a result of such Fundamental Transaction by a holder of
the number of Ordinary Shares for which this Purchase Warrant is exercisable immediately prior to such Fundamental Transaction. For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternative Consideration
based on the amount of Alternative Consideration issuable in respect of one Ordinary Share in such Fundamental Transaction, and the Company
shall apportion the Exercise Price among the Alternative Consideration in a reasonable manner reflecting the relative value of any different
components of the Alternative Consideration. If holders of Ordinary Shares are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternative Consideration it receives
upon any exercise of this Purchase Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &quot;<B>Successor Entity</B>&quot;) to assume in writing all of the obligations
of the Company under this Purchase Warrant, and to deliver to the Holder in exchange for this Purchase Warrant a security of the Successor
Entity evidenced by a written instrument substantially similar in form and substance to this Purchase Warrant which is exercisable for
a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Ordinary Shares acquirable
and receivable upon exercise of this Purchase Warrant prior to such Fundamental Transaction, and with an exercise price which applies
the Exercise Price hereunder to such shares of capital stock (but taking into account the relative value of the Ordinary Shares pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Purchase Warrant immediately prior to the consummation of such Fundamental
Transaction). Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Purchase Warrant and the other Transaction Documents
referring to the &quot;Company&quot; shall refer instead to the Successor Entity), and may exercise every right and power of, the Company
and shall assume all of the obligations of the Company, under this Purchase Warrant and the other Transaction Documents with the same
effect as if such Successor Entity had been named as the Company herein. &ldquo;Transaction Documents&rdquo; shall mean the Underwriting
Agreement and any other agreement entered into between the Company and the Holder in connection therewith or herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.5 &nbsp; <U>Changes in Form
of Purchase Warrant</U>. This form of Purchase Warrant need not be changed because of any change pursuant to this&nbsp;<U>Section 6.1</U>,
and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Ordinary Shares as are stated
in the Purchase Warrant initially issued pursuant to the Underwriting Agreement. The acceptance by any Holder of the issuance of new Purchase
Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after the date
hereof or the computation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.2 <U>Substitute Purchase
Warrant</U>. In case of any consolidation of the Company with, or share reconstruction or amalgamation of the Company with or into, another
corporation (other than a consolidation or share reconstruction or amalgamation which does not result in any reclassification or change
of the outstanding Ordinary Shares), the corporation formed by such consolidation or share reconstruction or amalgamation shall execute
and deliver to the Holder a supplemental Purchase Warrant providing that the Holder of each Purchase Warrant then outstanding or to be
outstanding shall have the right thereafter (until the stated expiration of such Purchase Warrant) to receive, upon exercise of such Purchase
Warrant, the kind and amount of Ordinary Shares and other securities and property receivable upon such consolidation or share reconstruction
or amalgamation, by a holder of the number of Ordinary Shares of the Company for which such Purchase Warrant might have been exercised
immediately prior to such consolidation, share reconstruction or amalgamation, sale or transfer. Such supplemental Purchase Warrant shall
provide for adjustments which shall be identical to the adjustments provided for in this&nbsp;<U>Section 6</U>. The above provision of
this&nbsp;<U>Section 6</U>&nbsp;shall similarly apply to successive consolidations or share reconstructions or amalgamations.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.3 <U>Elimination of Fractional
Interests</U>. The Company shall not be required to issue certificates representing fractions of Ordinary Shares upon the exercise of
the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it being the intent of
the parties that all fractional interests shall be eliminated by rounding any fraction up or down, as the case may be, to the nearest
whole number of Ordinary Shares or other securities, properties or rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7. <U>Reservation and Listing</U>. The Company
covenants and agrees that, upon exercise of this Purchase Warrant and payment of the Exercise Price therefor, in accordance with the terms
hereby, all Ordinary Shares and other securities issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable
and not subject to preemptive rights of any shareholder. As long as this Purchase Warrant shall be outstanding, the Company shall use
its commercially reasonable efforts to cause all Ordinary Shares issuable upon exercise of this Purchase Warrant to be listed (subject
to official notice of issuance) on all national securities exchanges (or, if applicable, on the OTCQB Market or any successor quotation
system) on which the Ordinary Shares issued to the public in the Offering may then be listed and/or quoted (if at all).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">8. <U>Certain Notice Requirements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.1 <U>Holder&rsquo;s Right
to Receive Notice</U>. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to receive notice
as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the Company.
If, however, at any time prior to the expiration of this Purchase Warrant and its exercise, any of the events described in&nbsp;<U>Section
8.2</U>&nbsp;shall occur, then, in one or more of said events, the Company shall give written notice of such event at least fifteen days
prior to the date fixed as a record date or the date of closing the transfer books (the &ldquo;<B>Notice Date</B>&rdquo;) for the determination
of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled
to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of the closing
of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice
given to the other shareholders of the Company at the same time and in the same manner that such notice is given to the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.2 <U>Events Requiring Notice</U>.
The Company shall be required to give the notice described in this&nbsp;<U>Section 8</U>&nbsp;upon one or more of the following events:
(i) if the Company shall take a record of the holders of its Ordinary Shares for the purpose of entitling them to receive a dividend or
distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings, as indicated
by the accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company shall offer to all the holders
of its Ordinary Shares any additional shares of capital stock of the Company or securities convertible into or exchangeable for shares
of capital stock of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation or winding
up of the Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale of all or substantially
all of its property, assets and business shall be proposed.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.3 <U>Notice of Change in
Exercise Price</U>. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to&nbsp;<U>Section 6</U>&nbsp;hereof,
send notice to the Holders of such event and change (&ldquo;<B>Price Notice</B>&rdquo;). The Price Notice shall describe the event causing
the change and the method of calculating same and shall be certified as being true and accurate by the Company&rsquo;s Chief Financial
Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.4 <U>Transmittal of Notices</U>.
All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall be deemed to have been
duly made if made in accordance with the notice provisions of the Underwriting Agreement to the addresses and contact information for
the Holder appearing on the books and records of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>If to the Holder, then to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Boustead Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">6 Venture, Suite 265</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Irvine, CA 92618</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attn: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Keith Moore</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Attn: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Daniel
J. McClory</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">keith@boustead1828.com</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">dan@boustead1828.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>With a copy to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Sichenzia Ross Ference LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">1185 Avenue of the Americas, 31st Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">New York, NY 10036</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">Attn:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Benjamin Tan, Esq.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">btan@srf.law</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>If to the Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">VCI Global Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">B03-C-8 Menara 3A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">KL Eco City, No. 3 Jalan Bangsar</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">59200 Kuala Lumpur</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Attn: Chairman and Chief Executive
Officer, Victor Hoo</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Email: datovictor@v-capital.co</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>With a copy (which shall not constitute
notice) to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Carmel, Milazzo &amp; Feil LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">55 West 39th Street, 4th Floor,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">New York, NY 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Attn: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ross David
Carmel, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Email: &nbsp;&nbsp;&nbsp;&nbsp;rcarmel@cmfllp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.1 <U>Amendments</U>. The
Company and the Underwriter may from time to time supplement or amend this Purchase Warrant without the approval of any of the Holders
in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with any
other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company and the
Underwriter may deem necessary or desirable and that the Company and the Underwriter deem shall not adversely affect the interest of the
Holders, in their sole and absolute discretion. All other modifications or amendments shall require the written consent of and be signed
by the party against whom enforcement of the modification or amendment is sought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.2 <U>Headings</U>. The headings
contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning or interpretation
of any of the terms or provisions of this Purchase Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.3. <U>Entire Agreement</U>.
This Purchase Warrant constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and supersedes
all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.4 <U>Binding Effect</U>.
This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their permitted assignees,
respective successors, legal representative and assigns, and no other person shall have or be construed to have any legal or equitable
right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions herein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.5 <U>Governing Law; Submission
to Jurisdiction; Trial by Jury</U>. This Purchase Warrant shall be governed by and construed and enforced in accordance with the laws
of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that any action, proceeding
or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought and enforced in the New York Supreme
Court, County of New York, or in the United States District Court for the Southern District of New York, and irrevocably submits to such
jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such
courts represent an inconvenient forum. Any process or summons to be served upon the Company may be served by transmitting a copy thereof
by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in&nbsp;<U>Section
8</U>&nbsp;hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding
or claim. The Company and the Holder agree that the prevailing party(ies) in any such action shall be entitled to recover from the other
party(ies) all of its reasonable attorneys&rsquo; fees and expenses relating to such action or proceeding and/or incurred in connection
with the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders
and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.6 <U>Waiver, etc</U>. The
failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not be deemed or construed
to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or any provision hereof or the right
of the Company or any Holder to thereafter enforce each and every provision of this Purchase Warrant. No waiver of any breach, non-compliance
or non-fulfillment of any of the provisions of this Purchase Warrant shall be effective unless set forth in a written instrument executed
by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or
non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.7 <U>Exchange Agreement</U>.
As a condition of the Holder&rsquo;s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any time prior to the complete
exercise of this Purchase Warrant by Holder, if the Company and the Underwriter enter into an agreement (&ldquo;<B>Exchange Agreement</B>&rdquo;)
pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash or a combination of both,
then Holder shall agree to such exchange and become a party to the Exchange Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.8 <U>Holder Not Deemed a
Shareholder</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder of this Purchase Warrant,
shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall
anything contained in this Purchase Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Purchase
Warrant, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any corporate action (whether
any reorganization, issue of share, reclassification of share, consolidation, merger, conveyance or otherwise), receive notice of meetings,
receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Ordinary Shares which it is then entitled
to receive upon the due exercise of this Purchase Warrant. In addition, nothing contained in this Purchase Warrant shall be construed
as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Purchase Warrant or otherwise) or as a shareholder
of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page to Follow]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>IN WITNESS WHEREOF</B>, the Company has caused this Purchase Warrant
to be signed by its duly authorized officer as of the __th day of 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>VCI GLOBAL LIMITED</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: Victor Hoo </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: Chairman and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exercise Notice</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Form to be used to exercise Purchase Warrant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Date: __________, 20___</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned hereby elects
irrevocably to exercise the Purchase Warrant for ______ Ordinary Shares of <FONT STYLE="text-transform: uppercase">VCI GLOBAL Limited</FONT>,
a British Virgin Islands company (the &ldquo;<B>Company</B>&rdquo;) and hereby makes payment of $____ (at the rate of $____ per Ordinary
Share) in payment of the Exercise Price pursuant thereto. Please issue the Ordinary Shares as to which this Purchase Warrant is exercised
in accordance with the instructions given below and, if applicable, a new Purchase Warrant representing the number of Ordinary Shares
for which this Purchase Warrant has not been exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned hereby elects
irrevocably to convert its right to purchase ___ Ordinary Shares under the Purchase Warrant for ______ Ordinary Shares, as determined
in accordance with the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">dividing [(A-B) (X)] by (A),
where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: -27pt">(A) = the Fair Market
Value of one Ordinary Share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B) = the Exercise Price of
this Purchase Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-align: justify; text-indent: -22.5pt">(X) = the number
of Ordinary Shares underlying the Purchase Warrant that would be issuable upon exercise of this Purchase Warrant in accordance with the
terms of this Purchase Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-align: justify; text-indent: -22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned agrees and
acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement with respect to the calculation
shall be resolved by the Company in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please issue the Ordinary
Shares as to which this Purchase Warrant is exercised in accordance with the instructions given and, if applicable, a new Purchase Warrant
representing the number of Ordinary Shares for which this Purchase Warrant has not been converted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Signature Guaranteed</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form to be used to assign Purchase Warrant:
ASSIGNMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(To be executed by the registered Holder to effect a transfer of the
within Purchase Warrant):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;does
hereby sell, assign and transfer unto the right to purchase&nbsp;[&#9679;]<B>&nbsp;</B>ordinary shares of VCI GLOBAL <FONT STYLE="text-transform: uppercase">Limited</FONT>,
a British Islands company (the &ldquo;<B>Company</B>&rdquo;), evidenced by the Purchase Warrant and does hereby authorize the Company
to transfer such right on the books of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: , 20__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signature Guaranteed</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOTICE: The signature to this
form must correspond with the name as written upon the face of the within Purchase Warrant without alteration or enlargement or any change
whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered
national securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INSTRUCTIONS FOR REGISTRATION OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Print in Block Letters)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOTICE: The signature to this
form must correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement or any change whatsoever,
and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered national
securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>cm299_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>THE REGISTERED HOLDER OF THIS PURCHASE WARRANT
BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED
HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD
OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE EFFECTIVE DATE OF THE REGISTRATION STATEMENT TO ANYONE OTHER THAN (I) BOUSTEAD SECURITIES,
LLC, OR A REPRESENTATIVE OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF BOUSTEAD SECURITIES,
LLC, OR OF ANY SUCH UNDERWRITERS OR SELECTED DEALER.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNDERWRITER&rsquo;S WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FOR THE PURCHASE OF 89,600 ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>VCI GLOBAL LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. <U>Purchase Warrant</U>. THIS CERTIFIES THAT, pursuant
to that certain Underwriting Agreement by and between VCI Global Limited, a British Virgin Islands company (the &ldquo;<B>Company</B>&rdquo;),
on one hand, and Boustead Securities, LLC (the &ldquo;<B>Holder</B>&rdquo;), on the other hand, dated April 13, 2023 (the &ldquo;<B>Underwriting
Agreement</B>&rdquo;), the Holder, as registered owner of this Purchase Warrant, is entitled, at any time or from time to time from the
date of issuance on April 17, 2023 to on or before 5:00 p.m., Eastern time, on April 13, 2028 (the &ldquo;<B>Expiration Date</B>&rdquo;,
which date shall be no more than five years from the commencement of sales of the initial public offering pursuant to the Underwriting
Agreement), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 89,600 ordinary shares (the &ldquo;<B>Shares</B>&rdquo;)
of the Company, no par value per ordinary share (the &ldquo;<B>Ordinary Shares</B>&rdquo;), subject to adjustment as provided in&nbsp;<U>Section
6</U>&nbsp;hereof. If the Expiration Date is a day on which banking institutions are authorized by law or executive order to close, then
this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During
the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase
Warrant is initially exercisable at $4.00 per Ordinary Share (100% of Offering price);&nbsp;<I>provided, however,</I>&nbsp;that upon the
occurrence of any of the events specified in&nbsp;<U>Section 6</U>&nbsp;hereof, the rights granted by this Purchase Warrant, including
the exercise price per Ordinary Share and the number of Ordinary Shares to be received upon such exercise, shall be adjusted as therein
specified. The term &ldquo;<B>Exercise Price</B>&rdquo; shall mean the initial exercise price as set forth above or the adjusted exercise
price as a result of the events set forth in Section 6 below, depending on the context. Capitalized terms not defined herein shall have
the meaning ascribed to them in the Underwriting Agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">2. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.1 <U>Exercise Form</U>. In order
to exercise this Purchase Warrant, the exercise form attached hereto as&nbsp;<U>Exhibit A</U>&nbsp;must be duly executed and completed
and delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Ordinary Shares being purchased
payable in cash by wire transfer of immediately available funds to an account designated by the Company or by certified check. If the
subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration Date, this Purchase
Warrant shall become and be void without further force or effect, and all rights represented hereby shall cease and expire.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.2 <U>Cashless Exercise</U>.
This Purchase Warrant may be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder
shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63pt; text-align: justify; text-indent: -27pt">(A) = the Fair Market
Value of one Ordinary Share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(B) = the Exercise Price of this
Purchase Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.5pt; text-align: justify; text-indent: -22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.5pt; text-align: justify; text-indent: -22.5pt">(X) = the number
of Ordinary Shares underlying the Purchase Warrant that would be issuable upon exercise of this Purchase Warrant in accordance with the
terms of this Purchase Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If Shares are issued in such a
cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Shares shall take
on the registered characteristics of the Purchase Warrants being exercised. The Company agrees not to take any position contrary to this
Section 2.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything herein
to the contrary, on the Expiration Date, this Purchase Warrant shall be automatically exercised via cashless exercise pursuant to this
Section 2.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;Fair Market Value&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the common stock is then listed or
quoted on a Trading Market, the value shall be deemed to be the highest intra-day or closing price on any trading day on such Trading
Market on which the common stock is then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)) during the five trading days preceding the exercise, (b) if OTCQB or OTCQX is not an Trading
Market, the value shall be deemed to be the highest intra-day or closing price on any trading day on the OTCQB or OTCQX on which the common
stock is then quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York
City time)) during the five trading days preceding the exercise, as applicable, (c) if the common stock is not then listed or quoted for
trading on OTCQB or OTCQX and if prices for the common stock are then reported in the &ldquo;Pink Sheets&rdquo; published by OTC Markets
Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the &ldquo;OTC Markets Group&rdquo;,
the value shall be deemed to be the highest intra-day or closing price on any trading day on the Pink Sheets on which the common stock
is then quoted as reported by OTC Markets Group (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City
time)) during the five trading days preceding the exercise, or (d) in all other cases, the fair market value of a share of common stock
as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;Trading Market&rdquo; means
the NASDAQ Stock Market LLC, or any of the following other markets or exchanges on which the Ordinary Shares are listed or quoted for
trading on the date in question: the NYSE American, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange
(or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Upon a cashless exercise of this
Purchase Warrant pursuant to this Section 2.2 the Ordinary Shares to be issued to Holder shall be paid up out of any of the Company's
freely distributable reserves, other than share premium reserves maintained by the Company for the benefit of holders of preferred shares,
or out of any of the Company's statutory reserves which may be converted into share capital, to be determined by the Company's board of
directors in its sole discretion. A cashless exercise of this Purchase Warrant pursuant to this Section 2.2 shall only be permitted to
the extent the Company has sufficient freely distributable reserves, other than share premium reserves maintained by the Company for the
benefit of holders of preferred shares, or reserves which may be converted into share capital.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.3 <U>Legend</U>. Each certificate
for the securities purchased under this Purchase Warrant shall bear the following legends unless such securities have been registered
under the Securities Act of 1933, as amended (the &ldquo;<B>Act</B>&rdquo;), or are exempt from registration under the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">(i) &ldquo;THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;ACT&rdquo;), OR APPLICABLE STATE LAW. NEITHER
THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED FOR SALE, SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW WHICH, IN THE OPINION OF
COUNSEL TO THE COMPANY, IS AVAILABLE.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">(ii) Any legend required by the securities
laws of any state to the extent such laws are applicable to the Shares represented by a certificate, instrument, or book entry so legended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3. <U>Transfer</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.1 <U>General Restrictions</U>.
The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder will not: (a) sell, transfer,
assign, pledge or hypothecate this Purchase Warrant (or any Shares issuable upon the exercise of this Purchase Warrant) for a period of
one hundred eighty (180) days following the effective date of the Registration Statement (the &ldquo;<B>Effective Date</B>&rdquo;) to
anyone other than: (i) the Underwriter or a selected dealer participating in the Offering, or (ii) a bona fide officer or partner of the
Underwriter or of any such selected dealer, in each case in accordance with FINRA Conduct Rule 5110(e)(1), or (b) cause this Purchase
Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative, put or call transaction that would
result in the effective economic disposition of this Purchase Warrant or the securities hereunder, except as provided for in FINRA Rule
5110(e)(2). On and after that date that is one hundred eighty (180) days after the Effective Date, transfers to others may be made subject
to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder must deliver to
the Company the assignment form attached hereto as&nbsp;<U>Exhibit B</U>&nbsp;duly executed and completed, together with this Purchase
Warrant and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five (5) Business Days transfer
this Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase Warrant or Purchase Warrants of like tenor
to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Ordinary Shares purchasable hereunder
or such portion of such number as shall be contemplated by any such assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.2 <U>Restrictions Imposed by
the Act</U>. The securities evidenced by this Purchase Warrant shall not be transferred unless and until: (i) the Company has received
the opinion of counsel for the Company that the securities may be transferred pursuant to an exemption from registration under the Act
and applicable state securities laws, the availability of which is established to the reasonable satisfaction of the Company, (ii) a registration
statement or a post-effective amendment to the registration statement relating to the offer and sale of such securities that has been
declared effective by the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) and includes a current prospectus
or (iii) a registration statement, pursuant to which the Holder has exercised its registration rights pursuant to&nbsp;<U>Section 4.1
</U>herein, relating to the offer and sale of such securities has been filed and declared effective by the Commission and compliance with
applicable state securities law has been established.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4. <U>Registration Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.1 &ldquo;<U>Piggy-Back&rdquo;
Registration</U>. At any time after 180 days from the date hereof that all of the Shares may not be resold by the Holder pursuant to an
exemption from registration under the Securities Act upon exercise on a cashless basis and unless all of the Ordinary Shares underlying
the Purchase Warrant (collectively, the &ldquo;<B>Registrable Securities</B>&rdquo;) are included in an effective registration statement
with a current prospectus, the Holder shall have the right, until the Expiration Date, or the maximum time allowable under FINRA Rule
5110(g)(8), whichever is the earlier, to include the remaining Registrable Securities as part of any other registration of securities
filed by the Company (other than in connection with a transaction contemplated by Rule 145 promulgated under the Act or pursuant to Forms
S-8, F-3, F-4 or any equivalent forms);&nbsp;<I>provided, however</I>, that if, solely in connection with any primary underwritten public
offering for the account of the Company, the managing underwriter(s) thereof shall, in its reasonable discretion, impose a limitation
on the number of Registrable Securities which may be included in the registration statement because, in such underwriter(s)&rsquo; judgment,
marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall be obligated
to include in such registration statement only such limited portion of the Registrable Securities with respect to which the Holder requested
inclusion hereunder as the underwriter shall reasonably permit; and&nbsp;<I>further provided</I>&nbsp;that no such piggy-back rights shall
exist for so long as the Registrable Securities (which term shall include those paid as consideration pursuant to the cashless exercise
provisions of this Purchase Warrant) may be sold pursuant to Rule 144 of the Act without restriction. Any exclusion of Registrable Securities
shall be made pro rata among the Holders seeking to include Registrable Securities in proportion to the number of Registrable Securities
sought to be included by such Holders;&nbsp;<I>provided, however</I>, that the Company shall not exclude any Registrable Securities unless
the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such
registration statement or are not entitled to pro rata inclusion with the Registrable Securities. In the event of such a proposed registration,
the Company shall furnish the then Holders of outstanding Registrable Securities with not less than fifteen (15) days written notice prior
to the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration
statement filed by the Company until such time as all of the Registrable Securities have been sold by the Holder. The Holders of the Registrable
Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein by giving written notice, within seven (7) days of the
receipt of the Company&rsquo;s notice of its intention to file a registration statement. Except as otherwise provided in this Purchase
Warrant, there shall be no limit on the number of times the Holder may request registration under this&nbsp;<U>Section 4.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.2 <U>General Terms</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">4.2.1 <U>Expenses of Registration</U>.
The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 4 hereof, but the
Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent them
in connection with the sale of the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">4.2.2 <U>Indemnification</U>. The
Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder and each
person, if any, who controls such Holders within the meaning of Section 15 of the Act or Section 20 (a) of the Securities Exchange Act
of 1934, as amended (&ldquo;<B>Exchange Act</B>&rdquo;), against all loss, claim, damage, expense or liability (including all reasonable
attorneys&rsquo; fees and other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to
which any of them may become subject under the Act, the Exchange Act or otherwise, arising from such registration statement but only to
the same extent and with the same effect as the provisions pursuant to which the Company has agreed to indemnify the Underwriter contained
in Section 5 of the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">4.2.3 <U>Exercise of Purchase Warrant</U>.
Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s) to exercise their Purchase Warrant prior to or
after the initial filing of any registration statement or the effectiveness thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">4.2.4 <U>Documents to be Delivered
by Holder(s).</U>&nbsp;Each of the Holder(s) participating in any registration statement filed by the Company shall furnish to the Company
a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">4.2.5 <U>Damages</U>. Should the
registration or the effectiveness thereof required by&nbsp;<U>Section 4</U>&nbsp;hereof be delayed by the Company or the Company otherwise
fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available to the Holder(s),
be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened breach of such provisions
or the continuation of any such breach, without the necessity of proving actual damages and without the necessity of posting bond or other
security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5. <U>New Purchase Warrants to be Issued</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.1 <U>Partial Exercise or Transfer</U>.
Subject to the restrictions in&nbsp;<U>Section 3</U>&nbsp;hereof, this Purchase Warrant may be exercised or assigned in whole or in part.
In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant for cancellation, together with
the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax if exercised pursuant
to&nbsp;<U>Section 2.1</U>&nbsp;hereof, the Company shall cause to be delivered to the Holder without charge a new Purchase Warrant of
like tenor to this Purchase Warrant in the name of the Holder evidencing the right of the Holder to purchase the number of Ordinary Shares
purchasable hereunder as to which this Purchase Warrant has not been exercised or assigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.2 <U>Lost Certificate</U>. Upon
receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Purchase Warrant and of reasonably
satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase Warrant of like tenor and
date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft, mutilation or destruction shall constitute
a substitute contractual obligation on the part of the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">6. <U>Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.1 <U>Adjustments to Exercise
Price and Number of Ordinary Shares</U>. The Exercise Price and the number of Ordinary Shares underlying this Purchase Warrant shall be
subject to adjustment from time to time as hereinafter set forth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">6.1.1 <U>Share Dividends; Split
Ups</U>. If, after the date hereof, and subject to the provisions of&nbsp;<U>Section 6.3</U>&nbsp;below, the number of outstanding Ordinary
Shares is increased by a stock dividend payable in Ordinary Shares or by a split up of Ordinary Shares or other similar event, then, on
the effective day thereof, the number of Ordinary Shares purchasable hereunder shall be increased in proportion to such increase in outstanding
Ordinary Shares, and the Exercise Price shall be proportionately decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">6.1.2 <U>Aggregation of Ordinary
Shares</U>. If, after the date hereof, and subject to the provisions of&nbsp;<U>Section 6.3</U>&nbsp;below, the number of outstanding
Ordinary Shares is decreased by a consolidation, combination or reclassification of Ordinary Shares or other similar event, then, on the
effective date thereof, the number of Ordinary Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding
Ordinary Shares, and the Exercise Price shall be proportionately increased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">6.1.3 <U>Replacement of Ordinary
Shares upon Reorganization, etc</U>. In case of any reclassification or reorganization of the outstanding Ordinary Shares other than a
change covered by&nbsp;<U>Section 6.1.1</U>&nbsp;or&nbsp;<U>Section 6.1.2</U>&nbsp;hereof or that solely affects the par value of such
Ordinary Shares, or in the case of any share reconstruction or amalgamation or consolidation of the Company with or into another corporation
(other than a consolidation or share reconstruction or amalgamation in which the Company is the continuing corporation and that does not
result in any reclassification or reorganization of the outstanding Ordinary Shares), or in the case of any sale or conveyance to another
corporation or entity of the property of the Company as an entirety or substantially as an entirety in connection with which the Company
is dissolved, the Holder of this Purchase Warrant shall have the right thereafter (until the expiration of the right of exercise of this
Purchase Warrant) to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder immediately prior to such
event, the kind and amount of ordinary shares or other securities or property (including cash) receivable upon such reclassification,
reorganization, share reconstruction or amalgamation, or consolidation, or upon a dissolution following any such sale or transfer, by
a Holder of the number of Ordinary Shares of the Company obtainable upon exercise of this Purchase Warrant immediately prior to such event;
and if any reclassification also results in a change in Ordinary Shares covered by&nbsp;<U>Section 6.1.1</U>&nbsp;or&nbsp;<U>Section 6.1.2</U>,
then such adjustment shall be made pursuant to&nbsp;<U>Section 6.1.1</U>,&nbsp;<U>Section 6.1.2</U>&nbsp;and this&nbsp;<U>Section 6.1.3</U>.
The provisions of this&nbsp;<U>Section 6.1.3&nbsp;</U>shall similarly apply to successive reclassifications, reorganizations, share reconstructions
or amalgamations, or consolidations, sales or other transfers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">6.1.4 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fundamental
Transaction.</U>&nbsp;If, at any time while this Purchase Warrant is outstanding, (i) the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any direct or indirect purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Ordinary Shares are permitted to sell, tender or exchange their shares for
other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Ordinary Shares, (iv) the Company,
directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Ordinary
Shares or any compulsory share exchange pursuant to which the Ordinary Shares are effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spinoff or scheme of arrangement)
with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding Ordinary Shares (not
including any Ordinary Shares held by the other Person or other Persons making or party to, or associated or affiliated with, the other
Persons making or party to such stock or share purchase agreement or other business combination) (each a &quot;<B>Fundamental Transaction</B>&quot;),
then, upon any subsequent exercise of this Purchase Warrant, the Holder shall have the right to receive, for each Ordinary Share that
would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, the number of Ordinary
Shares of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional or alternative
consideration (the &quot;<B>Alternative Consideration</B>&quot;) receivable as a result of such Fundamental Transaction by a holder of
the number of Ordinary Shares for which this Purchase Warrant is exercisable immediately prior to such Fundamental Transaction. For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternative Consideration
based on the amount of Alternative Consideration issuable in respect of one Ordinary Share in such Fundamental Transaction, and the Company
shall apportion the Exercise Price among the Alternative Consideration in a reasonable manner reflecting the relative value of any different
components of the Alternative Consideration. If holders of Ordinary Shares are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternative Consideration it receives
upon any exercise of this Purchase Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &quot;<B>Successor Entity</B>&quot;) to assume in writing all of the obligations
of the Company under this Purchase Warrant, and to deliver to the Holder in exchange for this Purchase Warrant a security of the Successor
Entity evidenced by a written instrument substantially similar in form and substance to this Purchase Warrant which is exercisable for
a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Ordinary Shares acquirable
and receivable upon exercise of this Purchase Warrant prior to such Fundamental Transaction, and with an exercise price which applies
the Exercise Price hereunder to such shares of capital stock (but taking into account the relative value of the Ordinary Shares pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Purchase Warrant immediately prior to the consummation of such Fundamental
Transaction). Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Purchase Warrant and the other Transaction Documents
referring to the &quot;Company&quot; shall refer instead to the Successor Entity), and may exercise every right and power of, the Company
and shall assume all of the obligations of the Company, under this Purchase Warrant and the other Transaction Documents with the same
effect as if such Successor Entity had been named as the Company herein. &ldquo;Transaction Documents&rdquo; shall mean the Underwriting
Agreement and any other agreement entered into between the Company and the Holder in connection therewith or herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">6.1.5 &nbsp; <U>Changes in Form
of Purchase Warrant</U>. This form of Purchase Warrant need not be changed because of any change pursuant to this&nbsp;<U>Section 6.1</U>,
and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Ordinary Shares as are stated
in the Purchase Warrant initially issued pursuant to the Underwriting Agreement. The acceptance by any Holder of the issuance of new Purchase
Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after the date
hereof or the computation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.2 <U>Substitute Purchase Warrant</U>.
In case of any consolidation of the Company with, or share reconstruction or amalgamation of the Company with or into, another corporation
(other than a consolidation or share reconstruction or amalgamation which does not result in any reclassification or change of the outstanding
Ordinary Shares), the corporation formed by such consolidation or share reconstruction or amalgamation shall execute and deliver to the
Holder a supplemental Purchase Warrant providing that the Holder of each Purchase Warrant then outstanding or to be outstanding shall
have the right thereafter (until the stated expiration of such Purchase Warrant) to receive, upon exercise of such Purchase Warrant, the
kind and amount of Ordinary Shares and other securities and property receivable upon such consolidation or share reconstruction or amalgamation,
by a holder of the number of Ordinary Shares of the Company for which such Purchase Warrant might have been exercised immediately prior
to such consolidation, share reconstruction or amalgamation, sale or transfer. Such supplemental Purchase Warrant shall provide for adjustments
which shall be identical to the adjustments provided for in this&nbsp;<U>Section 6</U>. The above provision of this&nbsp;<U>Section 6</U>&nbsp;shall
similarly apply to successive consolidations or share reconstructions or amalgamations.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.3 <U>Elimination of Fractional
Interests</U>. The Company shall not be required to issue certificates representing fractions of Ordinary Shares upon the exercise of
the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it being the intent of
the parties that all fractional interests shall be eliminated by rounding any fraction up or down, as the case may be, to the nearest
whole number of Ordinary Shares or other securities, properties or rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">7. <U>Reservation and Listing</U>. The Company covenants
and agrees that, upon exercise of this Purchase Warrant and payment of the Exercise Price therefor, in accordance with the terms hereby,
all Ordinary Shares and other securities issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable and
not subject to preemptive rights of any shareholder. As long as this Purchase Warrant shall be outstanding, the Company shall use its
commercially reasonable efforts to cause all Ordinary Shares issuable upon exercise of this Purchase Warrant to be listed (subject to
official notice of issuance) on all national securities exchanges (or, if applicable, on the OTCQB Market or any successor quotation system)
on which the Ordinary Shares issued to the public in the Offering may then be listed and/or quoted (if at all).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">8. <U>Certain Notice Requirements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.1 <U>Holder&rsquo;s Right to
Receive Notice</U>. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to receive notice
as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the Company.
If, however, at any time prior to the expiration of this Purchase Warrant and its exercise, any of the events described in&nbsp;<U>Section
8.2</U>&nbsp;shall occur, then, in one or more of said events, the Company shall give written notice of such event at least fifteen days
prior to the date fixed as a record date or the date of closing the transfer books (the &ldquo;<B>Notice Date</B>&rdquo;) for the determination
of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled
to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of the closing
of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice
given to the other shareholders of the Company at the same time and in the same manner that such notice is given to the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.2 <U>Events Requiring Notice</U>.
The Company shall be required to give the notice described in this&nbsp;<U>Section 8</U>&nbsp;upon one or more of the following events:
(i) if the Company shall take a record of the holders of its Ordinary Shares for the purpose of entitling them to receive a dividend or
distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings, as indicated
by the accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company shall offer to all the holders
of its Ordinary Shares any additional shares of capital stock of the Company or securities convertible into or exchangeable for shares
of capital stock of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation or winding
up of the Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale of all or substantially
all of its property, assets and business shall be proposed.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.3 <U>Notice of Change in Exercise
Price</U>. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to&nbsp;<U>Section 6</U>&nbsp;hereof,
send notice to the Holders of such event and change (&ldquo;<B>Price Notice</B>&rdquo;). The Price Notice shall describe the event causing
the change and the method of calculating same and shall be certified as being true and accurate by the Company&rsquo;s Chief Financial
Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.4 <U>Transmittal of Notices</U>.
All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall be deemed to have been
duly made if made in accordance with the notice provisions of the Underwriting Agreement to the addresses and contact information for
the Holder appearing on the books and records of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><B>If to the Holder, then to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Boustead Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">6 Venture, Suite 265</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Irvine, CA 92618</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Attn: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Keith Moore</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Attn: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Daniel
J. McClory</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">keith@boustead1828.com</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">dan@boustead1828.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>With a copy to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Sichenzia Ross Ference LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">1185 Avenue of the Americas, 31st Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">New York, NY 10036</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">Attn:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Benjamin Tan, Esq.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">btan@srf.law</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><B>If to the Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">VCI Global Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">B03-C-8 Menara 3A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">KL Eco City, No. 3 Jalan Bangsar</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">59200 Kuala Lumpur</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Attn: Chairman and Chief Executive
Officer, Victor Hoo</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Email: datovictor@v-capital.co</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>With a copy (which shall not constitute
notice) to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Carmel, Milazzo &amp; Feil LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">55 West 39th Street, 4th Floor,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">New York, NY 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Attn: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ross David Carmel,
Esq.&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Email: &nbsp;&nbsp;&nbsp;rcarmel@cmfllp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.1 <U>Amendments</U>. The Company
and the Underwriter may from time to time supplement or amend this Purchase Warrant without the approval of any of the Holders in order
to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with any other provisions
herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company and the Underwriter may deem
necessary or desirable and that the Company and the Underwriter deem shall not adversely affect the interest of the Holders, in their
sole and absolute discretion. All other modifications or amendments shall require the written consent of and be signed by the party against
whom enforcement of the modification or amendment is sought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.2 <U>Headings</U>. The headings
contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning or interpretation
of any of the terms or provisions of this Purchase Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.3. <U>Entire Agreement</U>.
This Purchase Warrant constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and supersedes
all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.4 <U>Binding Effect</U>. This
Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their permitted assignees,
respective successors, legal representative and assigns, and no other person shall have or be construed to have any legal or equitable
right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions herein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.5 <U>Governing Law; Submission
to Jurisdiction; Trial by Jury</U>. This Purchase Warrant shall be governed by and construed and enforced in accordance with the laws
of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that any action, proceeding
or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought and enforced in the New York Supreme
Court, County of New York, or in the United States District Court for the Southern District of New York, and irrevocably submits to such
jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such
courts represent an inconvenient forum. Any process or summons to be served upon the Company may be served by transmitting a copy thereof
by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in&nbsp;<U>Section
8</U>&nbsp;hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding
or claim. The Company and the Holder agree that the prevailing party(ies) in any such action shall be entitled to recover from the other
party(ies) all of its reasonable attorneys&rsquo; fees and expenses relating to such action or proceeding and/or incurred in connection
with the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders
and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.6 <U>Waiver, etc</U>. The failure
of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not be deemed or construed to
be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or any provision hereof or the right
of the Company or any Holder to thereafter enforce each and every provision of this Purchase Warrant. No waiver of any breach, non-compliance
or non-fulfillment of any of the provisions of this Purchase Warrant shall be effective unless set forth in a written instrument executed
by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or
non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.7 <U>Exchange Agreement</U>.
As a condition of the Holder&rsquo;s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any time prior to the complete
exercise of this Purchase Warrant by Holder, if the Company and the Underwriter enter into an agreement (&ldquo;<B>Exchange Agreement</B>&rdquo;)
pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash or a combination of both,
then Holder shall agree to such exchange and become a party to the Exchange Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.8 <U>Holder Not Deemed a Shareholder</U>.
Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder of this Purchase Warrant, shall not be
entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained
in this Purchase Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Purchase Warrant, any of
the rights of a shareholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization,
issue of share, reclassification of share, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends
or subscription rights, or otherwise, prior to the issuance to the Holder of the Ordinary Shares which it is then entitled to receive
upon the due exercise of this Purchase Warrant. In addition, nothing contained in this Purchase Warrant shall be construed as imposing
any liabilities on the Holder to purchase any securities (upon exercise of this Purchase Warrant or otherwise) or as a shareholder of
the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[Signature Page to Follow]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>IN WITNESS WHEREOF</B>, the Company has caused this Purchase Warrant
to be signed by its duly authorized officer as of the 17th day of April 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>VCI GLOBAL LIMITED</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 46%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: Victor Hoo </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: Chairman and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Exercise Notice</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Form to be used to exercise Purchase Warrant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Date: __________, 20___</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The undersigned hereby elects
irrevocably to exercise the Purchase Warrant for ______ Ordinary Shares of <FONT STYLE="text-transform: uppercase">VCI GLOBAL Limited</FONT>,
a British Virgin Islands company (the &ldquo;<B>Company</B>&rdquo;) and hereby makes payment of $____ (at the rate of $____ per Ordinary
Share) in payment of the Exercise Price pursuant thereto. Please issue the Ordinary Shares as to which this Purchase Warrant is exercised
in accordance with the instructions given below and, if applicable, a new Purchase Warrant representing the number of Ordinary Shares
for which this Purchase Warrant has not been exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The undersigned hereby elects
irrevocably to convert its right to purchase ___ Ordinary Shares under the Purchase Warrant for ______ Ordinary Shares, as determined
in accordance with the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63pt; text-align: justify; text-indent: -27pt">(A) = the Fair Market
Value of one Ordinary Share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(B) = the Exercise Price of this
Purchase Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.5pt; text-align: justify; text-indent: -22.5pt">(X) = the number
of Ordinary Shares underlying the Purchase Warrant that would be issuable upon exercise of this Purchase Warrant in accordance with the
terms of this Purchase Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.5pt; text-align: justify; text-indent: -22.5pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The undersigned agrees and acknowledges
that the calculation set forth above is subject to confirmation by the Company and any disagreement with respect to the calculation shall
be resolved by the Company in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Please issue the Ordinary Shares
as to which this Purchase Warrant is exercised in accordance with the instructions given and, if applicable, a new Purchase Warrant representing
the number of Ordinary Shares for which this Purchase Warrant has not been converted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Signature Guaranteed</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Form to be used to assign Purchase Warrant: ASSIGNMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(To be executed by the registered Holder to effect a transfer of the within
Purchase Warrant):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FOR VALUE RECEIVED, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;does
hereby sell, assign and transfer unto the right to purchase&nbsp;[&#9679;]<B>&nbsp;</B>ordinary shares of VCI GLOBAL <FONT STYLE="text-transform: uppercase">Limited</FONT>,
a British Islands company (the &ldquo;<B>Company</B>&rdquo;), evidenced by the Purchase Warrant and does hereby authorize the Company
to transfer such right on the books of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dated: , 20__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Signature Guaranteed</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">NOTICE: The signature to this
form must correspond with the name as written upon the face of the within Purchase Warrant without alteration or enlargement or any change
whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered
national securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>INSTRUCTIONS FOR REGISTRATION OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Print in Block Letters)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">NOTICE: The signature to this
form must correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement or any change whatsoever,
and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered national
securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;<B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>cm299_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B><IMG SRC="cm299_ex99-1img01.jpg" ALT="">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>VCI Global Limited
Announces Pricing of Initial Public Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">KUALA LUMPUR,&nbsp;April 13, 2023&nbsp;- GlobeNewswire
&ndash; VCI Global Limited (NASDAQ: VCIG) (&ldquo;VCI Global&rdquo;, or the &ldquo;Company&rdquo;) today announced the pricing of its
initial public offering of 1,280,000 shares of its ordinary shares at a price to the public of $4.00 per share for a total of $5,120,000
of gross proceeds to the Company (the &quot;Offering&quot;), before deducting underwriting discounts, commissions and other Offering expenses.
In addition, VCI Global has granted the underwriters a 45-day option to purchase up to an additional 192,000 of its ordinary shares at
the public offering price of $4.00 per share, less the underwriting discounts and commissions, to cover over-allotments, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The shares are expected to begin trading on The Nasdaq
Capital Market today, April 13, 2023, under the ticker symbol &quot;VCIG.&quot; The Offering is expected to close on April 17, 2023 subject
to the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Boustead Securities, LLC and Sutter Securities, Inc.
are acting as the underwriters for the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A registration statement on Form F-1, as amended (File
No. 333-268109) relating to these securities was filed with the Securities and Exchange Commission (&quot;SEC&quot;) and was declared
effective on March 30, 2023. The Offering is being made only by means of a prospectus. A copy of the final prospectus relating to the
Offering will be filed with the SEC and will be available on the SEC's website at&nbsp;<I>www.sec.gov</I>. A copy of the final prospectus
relating to the Offering may be obtained, when available from Boustead Securities, LLC by way of emailing requests to&nbsp;<U>offerings@boustead1828.com</U>;
or by calling 1-949-502-4408; or by request by standard mail to Boustead Securities, LLC, Attention: Equity Capital Markets, 6 Venture,
Suite 395, Irvine, California 92618, USA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This press release shall not constitute an offer to
sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>About VCI Global Limited </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">VCI Global is a multi-disciplinary consulting group
with key advisory practices in the areas of business and technology. The Company provides business and boardroom strategy services, investor
relation services, and technology consultancy services.&nbsp;Its clients range from small-medium enterprises and government-linked agencies
to publicly traded companies across a broad array of industries. VCI Global operates solely in Malaysia, with clients predominantly from
Malaysia, but also serves some clients from China, Singapore, and the US.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For more information on the Company, please log on
to <I>https://v-capital.co/</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Cautionary Note Regarding Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This press release contains forward-looking statements
that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business
and other statements that are not historical facts, including statements which may be accompanied by the words &quot;intends,&quot; &quot;may,&quot;
&quot;will,&quot; &quot;plans,&quot; &quot;expects,&quot; &quot;anticipates,&quot; &quot;projects,&quot; &quot;predicts,&quot; &quot;estimates,&quot;
&quot;aims,&quot; &quot;believes,&quot; &quot;hopes,&quot; &quot;potential&quot; or similar words. Actual results could differ materially
from those described in these forward-looking statements due to certain factors, including without limitation, the Company's ability to
achieve profitable operations, customer acceptance of new products, the effects of the spread of Coronavirus (COVID-19) and future measures
taken by authorities in the countries wherein the Company has supply chain partners, the demand for the Company's products and the Company's
customers' economic condition, the impact of competitive products and pricing, successfully managing and, general economic conditions
and other risk factors detailed in the Company's filings with the United States Securities and Exchange Commission. The forward-looking
statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility
to update the forward-looking statements in this release, except in accordance with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>CONTACT INFORMATION:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Issued by Imej Jiwa Communications Sdn Bhd and
ICR Inc. on behalf of VCI Global Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For media queries, please contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Imej Jiwa Communications Sdn Bhd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Chris Chuah</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Email: <U>chris@imejjiwa.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>ICR Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Michael Bowen</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Vciglobal.ir@icrinc.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Public Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Brad Burgess</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Vciglobal.pr@icrinc.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Boustead Securities, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Underwriter</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dan McClory, Head of Equity Capital Markets</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>dan@boustead1828.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>cm299_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><IMG SRC="cm299_ex99-2img01.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>VCI Global Limited&rsquo;s
Stock (&ldquo;VCIG&rdquo;) Has Commenced Trading on The Nasdaq Capital Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">KUALA LUMPUR,&nbsp;April 13, 2023&nbsp;- GlobeNewswire
&ndash; VCI Global Limited (NASDAQ: VCIG) (&ldquo;VCI Global&rdquo;, or the &ldquo;Company&rdquo;) announced that its ordinary shares
have commenced trading on The Nasdaq Capital Market today under the ticker symbol &quot;VCIG.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 13, 2023, the Company priced its firm commitment
underwritten public offering (the &quot;Offering&quot;) of 1,280,000 shares of ordinary shares at a public offering price of $4.00 per
share. The gross proceeds to the Company from the Offering are expected to be $5,120,000 (not including any exercise by the underwriter
of its over-allotment option) before deducting underwriting discounts, commissions and other Offering expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Boustead Securities, LLC and Sutter Securities, Inc.
acted as the underwriters for the firm commitment Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A registration statement on Form F-1, as amended
(File No. 333-268109), filed by the Company with the Securities and Exchange Commission (the &quot;SEC&quot;), was declared effective
on March 30, 2023. The Offering has been made only by means of a prospectus. A copy of the final prospectus related to the Offering,
which was filed with the SEC, may be obtained, when available, from Boustead Securities, LLC, via email:&nbsp;<U>offerings@boustead1828.com</U>,
or by calling +1 (949) 502-4408, or by standard mail at Boustead Securities, LLC, Attn: Equity Capital Markets, 6 Venture, Suite 395,
Irvine, CA 92618, USA. In addition, a copy of the final prospectus, when available, relating to the Offering may be obtained via the
SEC's website at&nbsp;<I><U>www.sec.gov</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This press release shall not constitute an offer to
sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>About VCI Global Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">VCI Global is a multi-disciplinary consulting group
with key advisory practices in the areas of business and technology. The Company provides business and boardroom strategy services, investor
relation services, and technology consultancy services.&nbsp;Its clients range from small-medium enterprises and government-linked agencies
to publicly traded companies across a broad array of industries. VCI Global operates solely in Malaysia, with clients predominantly from
Malaysia, but also serves some clients from China, Singapore, and the US.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For more information on the Company, please log on
to <I>https://v-capital.co/</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Cautionary Note Regarding Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This press release contains forward-looking statements
that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business
and other statements that are not historical facts, including statements which may be accompanied by the words &quot;intends,&quot; &quot;may,&quot;
&quot;will,&quot; &quot;plans,&quot; &quot;expects,&quot; &quot;anticipates,&quot; &quot;projects,&quot; &quot;predicts,&quot; &quot;estimates,&quot;
&quot;aims,&quot; &quot;believes,&quot; &quot;hopes,&quot; &quot;potential&quot; or similar words. Actual results could differ materially
from those described in these forward-looking statements due to certain factors, including without limitation, the Company's ability to
achieve profitable operations, customer acceptance of new products, the effects of the spread of Coronavirus (COVID-19) and future measures
taken by authorities in the countries wherein the Company has supply chain partners, the demand for the Company's products and the Company's
customers' economic condition, the impact of competitive products and pricing, successfully managing and general economic conditions and
other risk factors detailed in the Company's filings with the United States Securities and Exchange Commission. The forward-looking statements
contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to
update the forward-looking statements in this release, except in accordance with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>CONTACT INFORMATION:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Issued by Imej Jiwa Communications Sdn Bhd and
ICR Inc. on behalf of VCI Global Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For media queries, please contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Imej Jiwa Communications Sdn Bhd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Chris Chuah</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Email: <U>chris@imejjiwa.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>ICR Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Michael Bowen</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Vciglobal.ir@icrinc.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Public Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Brad Burgess</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Vciglobal.pr@icrinc.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Boustead Securities, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Underwriter</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dan McClory, Head of Equity Capital Markets</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>dan@boustead1828.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>6
<FILENAME>cm299_ex99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><IMG SRC="cm299_ex99-3img01.jpg" ALT=""><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>VCI Global Limited
&ldquo;VCIG&rdquo; Closes Its First Day of Trading on The Nasdaq Capital Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">KUALA LUMPUR,&nbsp;April 13, 2023&nbsp;- GlobeNewswire
&ndash; VCI Global Limited (NASDAQ: VCIG) (&ldquo;VCI Global&rdquo;, or the &ldquo;Company&rdquo;) a multi-disciplinary consulting group
with key advisory practices in the areas of business and technology, announced that its ordinary shares have commenced trading on The
Nasdaq Capital Market today under the ticker symbol &quot;VCIG.&quot; The shares closed their first day of trading above the offering
price at $4.25.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 13, 2023, the Company priced its firm commitment
underwritten public offering (the &quot;Offering&quot;) of 1,280,000 shares of ordinary shares at a public offering price of $4.00 per
share. The gross proceeds to the Company were $5,120,000 before deducting underwriting discounts, commissions and other Offering expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Boustead Securities, LLC and Sutter Securities, Inc.
acted as the underwriters for the firm commitment Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A registration statement on Form F-1, as amended (File
No. 333-268109), filed by the Company with the Securities and Exchange Commission (the &quot;SEC&quot;), was declared effective on March
30, 2023. The Offering has been made only by means of a prospectus. A copy of the final prospectus related to the Offering may be obtained,
when available, from Boustead Securities, LLC, via email:&nbsp;<U>offerings@boustead1828.com</U>, or by calling +1 (949) 502-4408, or
by standard mail at Boustead Securities, LLC, Attn: Equity Capital Markets, 6 Venture, Suite 395, Irvine, CA 92618, USA. In addition,
a copy of the final prospectus, when available, relating to the Offering may be obtained via the SEC's website at&nbsp;<I><U>www.sec.gov</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This press release shall not constitute an offer to
sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>About VCI Global Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">VCI Global is a multi-disciplinary consulting group
with key advisory practices in the areas of business and technology. The Company provides business and boardroom strategy services, investor
relation services, and technology consultancy services.&nbsp;Its clients range from small-medium enterprises and government-linked agencies
to publicly traded companies across a broad array of industries. VCI Global operates solely in Malaysia, with clients predominantly from
Malaysia, but also serves some clients from China, Singapore, and the US.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For more information on the Company, please log on
to <I>https://v-capital.co/</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Cautionary Note Regarding Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This press release contains forward-looking statements
that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business
and other statements that are not historical facts, including statements which may be accompanied by the words &quot;intends,&quot; &quot;may,&quot;
&quot;will,&quot; &quot;plans,&quot; &quot;expects,&quot; &quot;anticipates,&quot; &quot;projects,&quot; &quot;predicts,&quot; &quot;estimates,&quot;
&quot;aims,&quot; &quot;believes,&quot; &quot;hopes,&quot; &quot;potential&quot; or similar words. Actual results could differ materially
from those described in these forward-looking statements due to certain factors, including without limitation, the Company's ability to
achieve profitable operations, customer acceptance of new products, the effects of the spread of Coronavirus (COVID-19) and future measures
taken by authorities in the countries wherein the Company has supply chain partners, the demand for the Company's products and the Company's
customers' economic condition, the impact of competitive products and pricing, successfully managing and general economic conditions and
other risk factors detailed in the Company's filings with the United States Securities and Exchange Commission. The forward-looking statements
contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to
update the forward-looking statements in this release, except in accordance with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>CONTACT INFORMATION:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Issued by Imej Jiwa Communications Sdn Bhd and
ICR Inc. on behalf of VCI Global Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For media queries, please contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Imej Jiwa Communications Sdn Bhd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Chris Chuah</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Email: <U>chris@imejjiwa.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>ICR Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Michael Bowen</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Vciglobal.ir@icrinc.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Public Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Brad Burgess</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Vciglobal.pr@icrinc.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Boustead Securities, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Underwriter</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dan McClory, Head of Equity Capital Markets</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>dan@boustead1828.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>7
<FILENAME>cm299_ex99-4.htm
<DESCRIPTION>EXHIBIT 99.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Exhibit 99.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><IMG SRC="cm299_ex99-4img01.jpg" ALT="" STYLE="height: 97px; width: 100px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VCI
Global Limited Announces Closing of $5.12 Million Initial Public Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KUALA
LUMPUR,&nbsp;April 17, 2023&nbsp;- GlobeNewswire &ndash; VCI Global Limited (NASDAQ: VCIG) (&ldquo;VCI Global&rdquo;, or the &ldquo;Company&rdquo;)
today announced the closing of its initial public offering (the &ldquo;Offering&rdquo;) of 1,280,000 ordinary shares at a price to the
public of $4.00 per share. The aggregate gross proceeds of the Offering were $5,120,000, prior to deducting underwriting discounts, commissions
and Offering expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boustead
Securities, LLC and Sutter Securities, Inc. are acting as the underwriters for the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
registration statement on Form F-1, as amended (File No. 333-268109) relating to these securities was filed with the Securities and Exchange
Commission (&quot;SEC&quot;) and was declared effective on March 30, 2023. The Offering is being made only by means of a prospectus.
A copy of the final prospectus relating to the Offering has been filed with the SEC and is available on the SEC's website at&nbsp;<I>www.sec.gov</I>.
A copy of the final prospectus relating to the Offering may be obtained, when available from Boustead Securities, LLC by way of emailing
requests to&nbsp;offerings@boustead1828.com; or by calling 1-949-502-4408; or by request by standard mail to Boustead Securities, LLC,
Attention: Equity Capital Markets, 6 Venture, Suite 395, Irvine, California 92618, USA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
VCI Global Limited </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VCI
Global is a multi-disciplinary consulting group with key advisory practices in the areas of business and technology. The Company provides
business and boardroom strategy services, investor relation services, and technology consultancy services.&nbsp;Its clients range from
small-medium enterprises and government-linked agencies to publicly traded companies across a broad array of industries. VCI Global operates
solely in Malaysia, with clients predominantly from Malaysia, but also serves some clients from China, Singapore, and the US.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information on the Company, please log on to <I>https://v-capital.co/</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cautionary
Note Regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements
regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may
be accompanied by the words &quot;intends,&quot; &quot;may,&quot; &quot;will,&quot; &quot;plans,&quot; &quot;expects,&quot; &quot;anticipates,&quot;
&quot;projects,&quot; &quot;predicts,&quot; &quot;estimates,&quot; &quot;aims,&quot; &quot;believes,&quot; &quot;hopes,&quot; &quot;potential&quot;
or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors,
including without limitation, the Company's ability to achieve profitable operations, customer acceptance of new products, the effects
of the spread of Coronavirus (COVID-19) and future measures taken by authorities in the countries wherein the Company has supply chain
partners, the demand for the Company's products and the Company's customers' economic condition, the impact of competitive products and
pricing, successfully managing and, general economic conditions and other risk factors detailed in the Company's filings with the United
States Securities and Exchange Commission. The forward-looking statements contained in this press release are made as of the date of
this press release, and the Company does not undertake any responsibility to update the forward-looking statements in this release, except
in accordance with applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="cm299_ex99-4img01.jpg" ALT="" STYLE="height: 97px; width: 100px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONTACT
INFORMATION:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issued
by Imej Jiwa Communications Sdn Bhd and ICR Inc. on behalf of VCI Global Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
media queries, please contact:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Imej
Jiwa Communications Sdn Bhd</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris
Chuah</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
chris@imejjiwa.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ICR
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
Bowen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vciglobal.ir@icrinc.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brad
Burgess</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vciglobal.pr@icrinc.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Boustead
Securities, LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriter</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dan
McClory, Head of Equity Capital Markets</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dan@boustead1828.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>cm299_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cm299_ex99-1img01.jpg
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M<" S+C  .$))300$       /' %:  ,;)4<< @   @ " #A"24T$)0
M$/SA'XG(M\EX+S1B- =8=^O_[@ .061O8F4 9,     !_]L A  ! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @("
M @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1" !$ $P# 1$
M A$! Q$!_\0 S@   0,% 0$             "0<("P $!08* P$!   ' 0
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..=]#S:.W5R_['W?EK_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>cm299_ex99-2img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cm299_ex99-2img01.jpg
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M<" S+C  .$))300$       /' %:  ,;)4<< @   @ " #A"24T$)0
M$/SA'XG(M\EX+S1B- =8=^O_[@ .061O8F4 9,     !_]L A  ! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @("
M @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1" !$ $P# 1$
M A$! Q$!_\0 S@   0,% 0$             "0<("P $!08* P$!   ' 0
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..=]#S:.W5R_['W?EK_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>cm299_ex99-3img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cm299_ex99-3img01.jpg
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M<" S+C  .$))300$       /' %:  ,;)4<< @   @ " #A"24T$)0
M$/SA'XG(M\EX+S1B- =8=^O_[@ .061O8F4 9,     !_]L A  ! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @("
M @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1" !$ $P# 1$
M A$! Q$!_\0 S@   0,% 0$             "0<("P $!08* P$!   ' 0
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..=]#S:.W5R_['W?EK_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>cm299_ex99-4img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cm299_ex99-4img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "$ (@# 2(  A$! Q$!_\0
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MU(,OQQI%W:Z'97TVGQF.9H\ZCMP\K["2/E&T#/'5LE,@XKD]!.-4C/H\9_\
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? %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
